Coty Inc 10-Q for FY2024 Q3
Coty Inc. (COTY)
10-Q
2024-05-07
For: 2024-03-31
View Original
Added on
April 10, 2026
About this 10-Q
Coty Inc filed this 10-Q on May 7, 2024, covering the quarter ended March 31, 2024 (FY2024 Q3).
Headline figures
Quarter ended March 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $1.39B
- up 7.5% from $1.29B a year earlier
- Net income
- $3.8M
- down 96.5% from net income of $108.4M a year earlier
- Diluted EPS
- $0.00
- compared with $0.12 a year earlier
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Form 10-Q
(Mark One)
| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||||||
| FOR THE QUARTERLY PERIOD ENDED | ||||||||
| OR | ||||||||
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||||||
| FOR THE TRANSITION PERIOD FROM TO | ||||||||
| COMMISSION FILE NUMBER | ||||||||
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||||||||||
| | |||||||||||
| (Address of principal executive offices) | (Zip Code) | ||||||||||
(212 ) 389-7300
Registrant’s telephone number, including area code
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ý No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| ☒ | Accelerated filer | ☐ | |||||||||||||||
| Non-accelerated filer | ☐ | Smaller reporting company | |||||||||||||||
| Emerging growth company | |||||||||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨ | |||||||||||||||||
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ý
Securities Registered Pursuant to Section 12(b) of the Act:
| Title of each class | Trading symbol(s) | Name of each exchange on which registered | ||||||
At April 30, 2024, 867,838,983 shares of the registrant’s Class A Common Stock, $0.01 par value, were outstanding.
COTY INC.
INDEX TO FORM 10-Q
| Page | ||||||||
PART I. FINANCIAL INFORMATION
Item 1. Condensed Consolidated Financial Statements
COTY INC. & SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In millions, except per share data)
(Unaudited)
| Three Months Ended March 31, | Nine Months Ended March 31, | ||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
| Net revenues | $ | $ | $ | $ | |||||||||||||||||||
| Cost of sales | |||||||||||||||||||||||
| Gross profit | |||||||||||||||||||||||
| Selling, general and administrative expenses | |||||||||||||||||||||||
| Amortization expense | |||||||||||||||||||||||
| Restructuring costs | ( | ( | |||||||||||||||||||||
| Operating income | |||||||||||||||||||||||
| Interest expense, net | |||||||||||||||||||||||
| Other expense (income), net | ( | ( | |||||||||||||||||||||
| Income before income taxes | |||||||||||||||||||||||
| (Benefit) provision for income taxes | ( | ||||||||||||||||||||||
| Net income | |||||||||||||||||||||||
| Net income (loss) attributable to noncontrolling interests | ( | ||||||||||||||||||||||
| Net income attributable to redeemable noncontrolling interests | |||||||||||||||||||||||
| Net income attributable to Coty Inc. | $ | $ | $ | $ | |||||||||||||||||||
| Amounts attributable to Coty Inc. | |||||||||||||||||||||||
| Net income attributable to Coty Inc. | |||||||||||||||||||||||
| Convertible Series B Preferred Stock dividends | ( | ( | ( | ( | |||||||||||||||||||
| Net income attributable to common stockholders | $ | $ | $ | $ | |||||||||||||||||||
| Earnings per common share: | |||||||||||||||||||||||
| Earnings per common share - basic | $ | $ | |||||||||||||||||||||
| Earnings per common share - diluted | |||||||||||||||||||||||
| Weighted-average common shares outstanding: | |||||||||||||||||||||||
| Basic | |||||||||||||||||||||||
| Diluted | |||||||||||||||||||||||
See notes to Condensed Consolidated Financial Statements.
1
COTY INC. & SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(In millions)
(Unaudited)
| Three Months Ended March 31, | Nine Months Ended March 31, | ||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
| Net income | $ | $ | $ | $ | |||||||||||||||||||
| Other comprehensive income (loss): | |||||||||||||||||||||||
| Foreign currency translation adjustment | ( | ( | |||||||||||||||||||||
Net unrealized derivative gain (loss) on cash flow hedges, net of taxes of $( | ( | ( | |||||||||||||||||||||
Pension and other post-employment benefits adjustment, net of tax of $ | ( | ( | ( | ( | |||||||||||||||||||
| Total other comprehensive (loss) income, net of tax | ( | ( | |||||||||||||||||||||
| Comprehensive (loss) income | ( | ||||||||||||||||||||||
| Comprehensive income attributable to noncontrolling interests: | |||||||||||||||||||||||
| Net income (loss) | ( | ||||||||||||||||||||||
| Foreign currency translation adjustment | ( | ( | ( | ||||||||||||||||||||
| Total comprehensive income (loss) attributable to noncontrolling interests | ( | ||||||||||||||||||||||
| Comprehensive income attributable to redeemable noncontrolling interests: | |||||||||||||||||||||||
| Net income | |||||||||||||||||||||||
| Foreign currency translation adjustment | ( | ||||||||||||||||||||||
| Total comprehensive income attributable to noncontrolling interests | |||||||||||||||||||||||
| Comprehensive (loss) income attributable to Coty Inc. | $ | ( | $ | $ | $ | ||||||||||||||||||
See notes to Condensed Consolidated Financial Statements.
2
COTY INC. & SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In millions, except per share data)
(Unaudited)
| March 31, 2024 | June 30, 2023 | ||||||||||
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | $ | |||||||||
| Restricted cash | |||||||||||
Trade receivables—less allowances of $ | |||||||||||
| Inventories | |||||||||||
| Prepaid expenses and other current assets | |||||||||||
| Total current assets | |||||||||||
| Property and equipment, net | |||||||||||
| Goodwill | |||||||||||
| Other intangible assets, net | |||||||||||
| Equity investments | |||||||||||
| Operating lease right-of-use assets | |||||||||||
| Deferred income taxes | |||||||||||
| Other noncurrent assets | |||||||||||
| TOTAL ASSETS | $ | $ | |||||||||
| LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ | $ | |||||||||
| Accrued expenses and other current liabilities | |||||||||||
| Short-term debt and current portion of long-term debt | |||||||||||
| Current operating lease liabilities | |||||||||||
| Income and other taxes payable | |||||||||||
| Total current liabilities | |||||||||||
| Long-term debt, net | |||||||||||
| Long-term operating lease liabilities | |||||||||||
| Pension and other post-employment benefits | |||||||||||
| Deferred income taxes | |||||||||||
| Other noncurrent liabilities | |||||||||||
| Total liabilities | |||||||||||
| COMMITMENTS AND CONTINGENCIES (See Note 17) | |||||||||||
CONVERTIBLE SERIES B PREFERRED STOCK, $ | |||||||||||
| REDEEMABLE NONCONTROLLING INTERESTS | |||||||||||
| EQUITY: | |||||||||||
Preferred Stock, $ | |||||||||||
Class A Common Stock, $ | |||||||||||
| Additional paid-in capital | |||||||||||
| Accumulated deficit | ( | ( | |||||||||
| Accumulated other comprehensive loss | ( | ( | |||||||||
Treasury stock—at cost, shares: | ( | ( | |||||||||
| Total Coty Inc. stockholders’ equity | |||||||||||
| Noncontrolling interests | |||||||||||
| Total equity | |||||||||||
| TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY | $ | $ | |||||||||
See notes to Condensed Consolidated Financial Statements.
3
COTY INC. & SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY
For the Three and Nine Months Ended March 31, 2024
(In millions, except per share data)
(Unaudited)
| Preferred Stock | Class A Common Stock | Stock to be issued | Additional Paid-in Capital | Receivable from sale of stock | (Accumulated Deficit) | Accumulated Other Comprehensive (Loss) Income | Treasury Stock | Total Coty Inc. Stockholders’ Equity | Noncontrolling Interests | Total Equity | Redeemable Noncontrolling Interests | Convertible Series B Preferred Stock | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BALANCE—July 1, 2023 | $ | $ | $ | $ | $ | $ | ( | $ | ( | $ | ( | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Issuance of Class A Common Stock in connection with global offering, net of offering costs | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Exercise of employee stock options and restricted stock units | ( | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares withheld for employee taxes | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation expense | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity Investment contribution for share-based compensation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Changes in dividends accrued | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends Accrued - Convertible Series B Preferred Stock | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends Paid - Convertible Series B Preferred Stock | — | — | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net income | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive loss | ( | ( | — | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment of redeemable noncontrolling interests to redemption value | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BALANCE—September 30, 2023 | $ | $ | $ | $ | $ | ( | $ | ( | $ | ( | $ | ( | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Issuance of Class A Common Stock in connection with global offering, net of offering costs | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reacquired Class A Common Stock for employee taxes | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Exercise of employee stock options and restricted stock units | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares withheld for employee taxes | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation expense | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity Investment contribution for share-based compensation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Changes in dividends accrued | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends Accrued - Convertible Series B Preferred Stock | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends Paid - Convertible Series B Preferred Stock | — | — | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net income | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Distribution to noncontrolling interests, net | — | — | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment of redeemable noncontrolling interests to redemption value | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BALANCE—December 31, 2023 | $ | $ | $ | $ | $ | $ | ( | $ | ( | $ | ( | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4
| Preferred Stock | Class A Common Stock | Stock to be issued | Additional Paid-in Capital | Receivable from sale of stock | (Accumulated Deficit) | Accumulated Other Comprehensive (Loss) Income | Treasury Stock | Total Coty Inc. Stockholders’ Equity | Noncontrolling Interests | Total Equity | Redeemable Noncontrolling Interests | Convertible Series B Preferred Stock | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Repurchase of Class A Common Stock pursuant to forward repurchase contracts | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reacquired Class A Common Stock for employee taxes and cancellation of restricted stock | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Exercise of employee stock options and restricted stock units and issuance of restricted stock | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares withheld for employee taxes | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation expense | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity Investment contribution for share-based compensation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Changes in dividends accrued | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends Accrued - Convertible Series B Preferred Stock | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends Paid - Convertible Series B Preferred Stock | — | — | — | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net income | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income | ( | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Distributions to noncontrolling interests, net | — | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment of redeemable noncontrolling interests to redemption value | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BALANCE—March 31, 2024 | $ | $ | $ | $ | ( | $ | ( | $ | ( | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5
COTY INC. & SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY
For the Three and Nine Months Ended March 31, 2023
(In millions, except per share data)
(Unaudited)
| Preferred Stock | Class A Common Stock | Additional Paid-in Capital | (Accumulated Deficit) | Accumulated Other Comprehensive (Loss) Income | Treasury Stock | Total Coty Inc. Stockholders’ Equity | Noncontrolling Interests | Total Equity | Redeemable Noncontrolling Interests | Convertible Series B Preferred Stock | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BALANCE—July 1, 2022 | $ | $ | $ | $ | ( | $ | ( | $ | ( | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reacquired Class A Common Stock for employee taxes | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Exercise of employee stock options and restricted stock units | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares withheld for employee taxes | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation expense | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends accrued- Convertible Series B Preferred Stock | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends paid - Convertible Series B Preferred Stock | — | — | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net (loss) income | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive loss | ( | ( | — | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment of redeemable noncontrolling interests to redemption value | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity investment contribution for share-based compensation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BALANCE—September 30, 2022 | $ | $ | $ | $ | ( | $ | ( | $ | ( | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Exercise of employee stock options and restricted stock units | ( | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares withheld for employee taxes | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation expense | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Changes in dividends accrued | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends accrued- Convertible Series B Preferred Stock | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends paid - Convertible Series B Preferred Stock | — | — | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net income (loss) | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive loss | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Distribution to noncontrolling interests, net | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment of redeemable noncontrolling interests to redemption value | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity investment contribution for share-based compensation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BALANCE—December 31, 2022 | $ | $ | $ | $ | ( | $ | ( | $ | ( | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Exercise of employee stock options and restricted stock units | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares withheld for employee taxes | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation expense | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends accrued- Convertible Series B Preferred Stock | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6
| Preferred Stock | Class A Common Stock | Additional Paid-in Capital | (Accumulated Deficit) | Accumulated Other Comprehensive (Loss) Income | Treasury Stock | Total Coty Inc. Stockholders’ Equity | Noncontrolling Interests | Total Equity | Redeemable Noncontrolling Interests | Convertible Series B Preferred Stock | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends paid - Convertible Series B Preferred Stock | — | — | — | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net income (loss) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive loss | ( | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Distribution to noncontrolling interests, net | — | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustment of redeemable noncontrolling interests to redemption value | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity investment contribution for share-based compensation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BALANCE—March 31, 2023 | $ | $ | $ | $ | ( | $ | ( | $ | ( | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
See notes to Condensed Consolidated Financial Statements.
7
COTY INC. & SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions)
(Unaudited)
| Nine Months Ended March 31, | |||||||||||
| 2024 | 2023 | ||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||
| Net income | $ | $ | |||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Depreciation and amortization | |||||||||||
| Non-cash lease expense | |||||||||||
| Deferred income taxes | |||||||||||
| Provision (releases) for bad debt, net | ( | ||||||||||
| Provision for pension and other post-employment benefits | |||||||||||
| Share-based compensation | |||||||||||
| Losses on disposals of long-term assets, net | |||||||||||
| Realized and unrealized gains from equity investments, net | ( | ( | |||||||||
| Foreign exchange effects | |||||||||||
| Unrealized gains on forward repurchase contracts, net | ( | ( | |||||||||
| Other | |||||||||||
| Change in operating assets and liabilities | |||||||||||
| Trade receivables | ( | ( | |||||||||
| Inventories | ( | ||||||||||
| Prepaid expenses and other current assets | ( | ||||||||||
| Accounts payable | ( | ||||||||||
| Accrued expenses and other current liabilities | ( | ||||||||||
| Operating lease liabilities | ( | ( | |||||||||
| Income and other taxes payable | ( | ||||||||||
| Other noncurrent assets | ( | ( | |||||||||
| Other noncurrent liabilities | ( | ( | |||||||||
| Net cash provided by operating activities | |||||||||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||||||
| Capital expenditures | ( | ( | |||||||||
| Proceeds from license termination, contingent consideration and sale of other long-term assets | |||||||||||
| Net cash used in investing activities | ( | ( | |||||||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||||||
| Proceeds from revolving loan facilities | |||||||||||
| Repayments of revolving loan facilities | ( | ( | |||||||||
| Proceeds from issuance of other long-term debt | |||||||||||
| Repayments of term loans and other long-term debt | ( | ( | |||||||||
| Proceeds from issuance of Class A Common Stock in connection with global offering, net of offering costs | |||||||||||
| Dividend payments on Common Stock and Convertible Series B Preferred Stock | ( | ( | |||||||||
| Net proceeds from issuance of Class A Common Stock | |||||||||||
| Net payments of foreign currency contracts | ( | ( | |||||||||
| Settlement and other payments related to forward repurchase contracts | ( | ||||||||||
| Distributions to noncontrolling interests and redeemable noncontrolling interests | ( | ( | |||||||||
| Payment of deferred financing fees | ( | ||||||||||
| All other | ( | ( | |||||||||
| Net cash used in financing activities | ( | ( | |||||||||
8
| EFFECT OF EXCHANGE RATES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH | ( | ( | |||||||||
| NET INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | |||||||||||
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH—Beginning of period | |||||||||||
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH—End of period | $ | $ | |||||||||
| SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION: | |||||||||||
| Cash paid during the period for interest | $ | $ | |||||||||
| Net cash paid for income taxes | |||||||||||
| SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES: | |||||||||||
| Accrued capital expenditure additions | $ | $ | |||||||||
| Non-cash exchange of June 2022 forward repurchase contracts for treasury stock | $ | $ | |||||||||
See notes to Condensed Consolidated Financial Statements.
9
COTY INC. & SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
($ in millions, except per share data)
(Unaudited)
1. DESCRIPTION OF BUSINESS
Coty Inc. and its subsidiaries (collectively, the “Company” or “Coty”) manufacture, market, sell and distribute branded beauty products, including fragrances, color cosmetics and skin & body related products throughout the world. Coty is a global beauty company with a rich entrepreneurial history and an iconic portfolio of brands.
The Company’s sales generally increase during the second fiscal quarter as a result of increased demand associated with the winter holiday season. Financial performance, working capital requirements, sales, cash flows and borrowings generally experience variability during the three to six months preceding the holiday season. Product innovations, new product launches and the size and timing of orders from the Company’s customers may also result in variability.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The unaudited interim Condensed Consolidated Financial Statements are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and include the Company’s consolidated domestic and international subsidiaries. Certain information and disclosures normally included in consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. Accordingly, these unaudited interim Condensed Consolidated Financial Statements and accompanying footnotes should be read in conjunction with the Company’s Consolidated Financial Statements as of and for the year ended June 30, 2023. In the opinion of management, all adjustments, of a normal recurring nature, considered necessary for a fair presentation have been included in the Condensed Consolidated Financial Statements. The results of operations for the three and nine months ended March 31, 2024 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending June 30, 2024. All dollar amounts (other than per share amounts) in the following discussion are in millions of United States (“U.S.”) dollars, unless otherwise indicated.
Restricted Cash
Equity Investments
The Company elected the fair value option to account for its investment in Rainbow JVCO LTD and subsidiaries (together, "Wella" or the “Wella Company”) to align with the Company’s strategy for this investment. The fair value is updated on a quarterly basis. The investment is classified within Level 3 in the fair value hierarchy because the Company estimates the fair value of the investment using a combination of the income approach, the market approach and private transactions, when applicable. Changes in the fair value of equity investment under the fair value option are recorded in Other expense (income), net within the Condensed Consolidated Statements of Operations (see Note 6—Equity Investments).
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the period reported. Significant accounting policies that contain subjective management estimates and assumptions include those related to revenue recognition, the net realizable value of inventory, the fair value of equity investments, the assessment of goodwill, other intangible assets and long-lived assets for
10
impairment and income taxes. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions. Significant changes, if any, in those estimates and assumptions will be reflected in the Condensed Consolidated Financial Statements in future periods.
Tax Information
The effective income tax rate for the three and nine months ended March 31, 2024 and 2023 was (158.8 )% and 21.0 %, respectively, and 34.3 % and 22.1 %, respectively.
The effective tax rate of (158.8 )% for the three months ended March 31, 2024 was primarily due to a benefit of $8.5 on the resolution of foreign uncertain tax positions compared to $3.4 of income in the period.
The effective tax rate of 21.0 % in the three months ended March 31, 2023 was increased due to a large limitation on the deductibility of executive stock compensation offset by large fair value gains related to the investment in the Wella business taxed at a rate below the statutory tax rate of 21% as well as a foreign exchange loss recognized on the repatriation of funds that were previously taxed.
The effective tax rate of 34.3 % in the nine months ended March 31, 2024 was driven up from the statutory tax rate of 21% due to an expense of $24.3 recognized in the current period on the revaluation of the Company's deferred tax liabilities due to a tax rate increase enacted in Switzerland, as well as the limitation on the deductibility of executive stock compensation.
The effective tax rate of 22.1 % in the nine months ended March 31, 2023 was increased from the statutory tax rate of 21% due to a large limitation on the deductibility of executive stock compensation. This increase was then offset by large fair value gains related to the investment in the Wella business taxed at a rate below the statutory tax rate of 21% as well as a foreign exchange loss recognized on repatriation of funds that were previously taxed.
The effective income tax rates vary from the U.S. federal statutory rate of 21% due to the effect of (i) jurisdictions with different statutory rates, including impacts of rate changes, (ii) adjustments to the Company’s unrealized tax benefits (“UTBs”) and accrued interest, (iii) non-deductible expenses, (iv) audit settlements and (v) valuation allowance changes.
As of March 31, 2024 and June 30, 2023, the gross amount of UTBs was $219.0 and $235.5 , respectively. As of March 31, 2024, the total amount of UTBs that, if recognized, would impact the effective income tax rate is $174.5 . As of March 31, 2024 and June 30, 2023, the liability associated with UTBs, including accrued interest and penalties, was $210.2 and $218.6 , respectively, which was recorded in Income and other taxes payable and Other noncurrent liabilities in the Condensed Consolidated Balance Sheets. The total interest and penalties recorded in the Condensed Consolidated Statements of Operations related to UTBs was $0.0 and $3.5 for the three months ended March 31, 2024 and 2023, respectively, and $2.0 and $4.9 for the nine months ended March 31, 2024 and 2023, respectively. The total gross accrued interest and penalties recorded in the Condensed Consolidated Balance Sheets as of March 31, 2024 and June 30, 2023 was $35.1 and $33.1 , respectively. On the basis of the information available as of March 31, 2024, it is reasonably possible that a decrease of up to $32.2 in UTBs may occur within twelve months as a result of projected resolutions of global tax examinations and a potential lapse of the applicable statutes of limitations.
Recent Accounting Pronouncements
In December 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which expands income tax disclosure requirements to include additional information related to the rate reconciliation of our effective tax rates to statutory rates, as well as additional disaggregation of taxes paid. The amendments in the ASU also remove disclosures related to certain unrecognized tax benefits and deferred taxes. ASU 2023-09 is effective for the Company in fiscal 2026. The amendments may be applied prospectively or retrospectively, and early adoption is permitted. The Company will adopt the standard and make the additional required disclosures beginning in the first quarter of fiscal 2026.
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which expands reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in the ASU require that a public entity discloses, on an annual and interim basis, significant segment expenses that are regularly provided to an entity's chief operating decision maker ("CODM"), a description of other segment items by reportable segment, and any additional measures of a segment's profit or loss used by the CODM when deciding how to allocate resources. Annual disclosures are required for the Company in fiscal 2025. Interim disclosures are required for periods within fiscal years beginning in the first quarter of fiscal 2026. Retrospective application is required for all prior periods presented, and early adoption is permitted. The Company will adopt the standard and make the additional required disclosures beginning in the fourth quarter of fiscal 2025.
11
3. SEGMENT REPORTING
Operating and reportable segments (referred to as “segments”) reflect the way the Company is managed and for which separate financial information is available and evaluated regularly by the Company's CODM in deciding how to allocate resources and assess performance. The Company has designated its Chief Executive Officer ("CEO") as the CODM.
Certain income and shared costs and the results of corporate initiatives are managed by Corporate. Corporate primarily includes stock compensation expense, restructuring and realignment costs, costs related to acquisition, divestiture and early license termination activities, and impairments of long-lived assets, goodwill and intangibles that are not attributable to ongoing operating activities of the segments. Corporate costs are not used by the CODM to measure the underlying performance of the segments.
With the exception of goodwill, the Company does not identify or monitor assets by segment. The Company does not present assets by reportable segment since various assets are shared between reportable segments. The allocation of goodwill by segment is presented in Note 7—Goodwill and Other Intangible Assets, net.
| Three Months Ended March 31, | Nine Months Ended March 31, | ||||||||||||||||||||||
| SEGMENT DATA | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||
| Net revenues: | |||||||||||||||||||||||
| Prestige | $ | $ | $ | $ | |||||||||||||||||||
| Consumer Beauty | |||||||||||||||||||||||
| Total | $ | $ | $ | $ | |||||||||||||||||||
| Operating income (loss): | |||||||||||||||||||||||
| Prestige | |||||||||||||||||||||||
| Consumer Beauty | ( | ( | |||||||||||||||||||||
| Corporate | ( | ( | ( | ( | |||||||||||||||||||
| Total | $ | $ | $ | $ | |||||||||||||||||||
| Reconciliation: | |||||||||||||||||||||||
| Operating income | |||||||||||||||||||||||
| Interest expense, net | |||||||||||||||||||||||
| Other expense (income), net | ( | ( | |||||||||||||||||||||
| Income before income taxes | $ | $ | $ | $ | |||||||||||||||||||
Presented below are the percentage of revenues associated with the Company’s product categories:
| Three Months Ended March 31, | Nine Months Ended March 31, | ||||||||||||||||||||||
| PRODUCT CATEGORY | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||
| Fragrance | % | % | % | % | |||||||||||||||||||
| Color Cosmetics | |||||||||||||||||||||||
| Body Care, Skin & Other | |||||||||||||||||||||||
| Total | % | % | % | % | |||||||||||||||||||
12
4. RESTRUCTURING COSTS
Restructuring costs for the three and nine months ended March 31, 2024 and 2023 are presented below:
| Three Months Ended March 31, | Nine Months Ended March 31, | ||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
| Current Restructuring Actions | $ | $ | $ | $ | |||||||||||||||||||
| Transformation Plan | ( | ( | ( | ( | |||||||||||||||||||
| Total | $ | $ | ( | $ | $ | ( | |||||||||||||||||
Current Restructuring Actions
The Company continues to analyze our cost structure and evaluate opportunities to streamline operations through a range of smaller initiatives and other cost reduction activities to optimize operations in select businesses. The Company has incurred cumulative restructuring charges of $37.2 related to approved initiatives through March 31, 2024, which have been recorded in Corporate. The liability balances were $36.3 (including certain actions that were accrued during fiscal 2023) and $0.0 at March 31, 2024 and June 30, 2023 respectively. The Company currently estimates that the total remaining accrual of $36.3 will result in cash expenditures of approximately $2.8 , $15.6 and $17.9 in fiscal 2024, 2025 and thereafter, respectively.
Transformation Plan
The Company previously announced a four-year plan to drive substantial improvement and optimization in the Company's businesses, under which the Company expected to incur restructuring and related costs (the “Transformation Plan”), which is now substantially complete. Of the expected costs, the Company has incurred cumulative restructuring charges of $214.6 related to approved initiatives through March 31, 2024, which have been recorded in Corporate. The related liability balances were $5.4 and $10.0 at March 31, 2024 and June 30, 2023, respectively. The Company currently estimates that the total remaining accrual of $5.4 will result in cash expenditures of approximately $0.9 and $4.5 in fiscal 2024 and 2025, respectively.
5. INVENTORIES
Inventories as of March 31, 2024 and June 30, 2023 are presented below:
| March 31, 2024 | June 30, 2023 | ||||||||||
| Raw materials | $ | $ | |||||||||
| Work-in-process | |||||||||||
| Finished goods | |||||||||||
| Total inventories | $ | $ | |||||||||
13
6. EQUITY INVESTMENTS
The Company's equity investments, classified as Equity investments in the Condensed Consolidated Balance Sheets are represented by the following:
| March 31, 2024 | June 30, 2023 | ||||||||||
| Equity method investments: | |||||||||||
KKW Holdings (a) | $ | $ | |||||||||
| Equity investments at fair value: | |||||||||||
Wella (b) | |||||||||||
| Total equity investments | $ | $ | |||||||||
(a)On January 4, 2021, the Company completed its purchase of 20 % of the outstanding equity of KKW Holdings. The Company accounts for this minority investment under the equity method, given it has the ability to exercise significant influence over, but not control, the investee. The carrying value of the Company’s investment includes basis differences allocated to amortizable intangible assets.
The Company recognized $0.7 and $0.8 , respectively, during the three months ended March 31, 2024 and 2023 and $2.4 and $2.8 , respectively, during the nine months ended March 31, 2024 and 2023 representing its share of the investee’s net loss in Other expense (income), net within the Condensed Consolidated Statements of Operations.
(b)As of March 31, 2024 and June 30, 2023, the Company's stake in Wella was 25.84 % and 25.85 %, respectively.
The following table presents summarized financial information of the Company’s equity method investees for the period ending March 31, 2024. Amounts presented represent combined totals at the investee level and not the Company’s proportionate share:
| Three Months Ended March 31, | Nine Months Ended March 31, | |||||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||||||
| Summarized Statements of Operations information: | ||||||||||||||||||||||||||
| Net revenues | $ | $ | $ | $ | ||||||||||||||||||||||
| Gross profit | ||||||||||||||||||||||||||
| Operating income | ||||||||||||||||||||||||||
| (Loss) before income taxes | ( | ( | ( | ( | ||||||||||||||||||||||
| Net income (loss) | ( | ( | ( | |||||||||||||||||||||||
The following table summarizes movements in equity investments with fair value option that are classified within Level 3 for the period ended March 31, 2024. There were no internal movements to or from Level 3 and Level 1 or Level 2 for the period ended March 31, 2024.
| Equity investments at fair value: | |||||
| Balance as of June 30, 2023 | $ | ||||
| Total gains included in earnings | |||||
| Balance as of March 31, 2024 | $ | ||||
14
Level 3 significant unobservable inputs sensitivity
The following table summarizes the significant unobservable inputs used in Level 3 valuation of the Company's investments carried at fair value as of March 31, 2024. Included in the table are the inputs or range of possible inputs that have an effect on the overall valuation of the financial instruments.
| Fair value | Valuation technique | Unobservable input | Range | ||||||||||||||||||||
| Equity investments at fair value | $ | Discounted cash flows | Discount rate | ||||||||||||||||||||
| Growth rate | |||||||||||||||||||||||
| Market multiple | Revenue multiple | ||||||||||||||||||||||
| EBITDA multiple | |||||||||||||||||||||||
(a)The primary unobservable inputs used in the fair value measurement of the Company's equity investments with fair value option, when using a discounted cash flow method, are the discount rate and revenue growth rate. Significant increases (decreases) in the discount rate in isolation would result in a significantly lower (higher) fair value measurement. The Company estimates the discount rate based on the investees' projected cost of equity and debt. The revenue growth rate is forecasted for future years by the investee based on their best estimates. Significant increases (decreases) in the revenue growth rate in isolation would result in a significantly higher (lower) fair value measurement.
(b)The primary unobservable inputs used in the fair value measurement of the Company's equity investments with fair value option, when using a market multiple method, are the revenue multiple and EBITDA multiple. Significant increases (decreases) in the revenue multiple or EBITDA multiple in isolation would result in a significantly higher (lower) fair value measurement. The market multiples are derived from a group of guideline public companies.
7. GOODWILL AND OTHER INTANGIBLE ASSETS, NET
Goodwill
Goodwill as of March 31, 2024 and June 30, 2023 is presented below:
| Prestige | Consumer Beauty | Total | |||||||||||||||
| Gross balance at June 30, 2023 | $ | $ | $ | ||||||||||||||
| Accumulated impairments | ( | ( | ( | ||||||||||||||
| Net balance at June 30, 2023 | $ | $ | $ | ||||||||||||||
| Changes during the period ended March 31, 2024 | |||||||||||||||||
| Foreign currency translation | ( | ( | ( | ||||||||||||||
| Gross balance at March 31, 2024 | $ | $ | $ | ||||||||||||||
| Accumulated impairments | ( | ( | ( | ||||||||||||||
| Net balance at March 31, 2024 | $ | $ | $ | ||||||||||||||
15
Other Intangible Assets, net
Other intangible assets, net as of March 31, 2024 and June 30, 2023 are presented below:
| March 31, 2024 | June 30, 2023 | ||||||||||
| Indefinite-lived other intangible assets | $ | $ | |||||||||
| Finite-lived other intangible assets, net | |||||||||||
| Total Other intangible assets, net | $ | $ | |||||||||
The changes in the carrying amount of indefinite-lived other intangible assets are presented below:
| Trademarks | Total | ||||||||||
| Gross balance at June 30, 2023 | $ | $ | |||||||||
| Accumulated impairments | ( | ( | |||||||||
| Net balance at June 30, 2023 | $ | $ | |||||||||
| Changes during the period ended March 31, 2024 | |||||||||||
| Foreign currency translation | ( | ( | |||||||||
| Gross balance at March 31, 2024 | $ | $ | |||||||||
| Accumulated impairments | ( | ( | |||||||||
| Net balance at March 31, 2024 | $ | $ | |||||||||
Intangible assets subject to amortization are presented below:
| Cost | Accumulated Amortization | Accumulated Impairment | Net | ||||||||||||||||||||
| June 30, 2023 | |||||||||||||||||||||||
| License agreements and collaboration agreements | $ | $ | ( | $ | ( | $ | |||||||||||||||||
| Customer relationships | ( | ( | |||||||||||||||||||||
| Trademarks | ( | ( | |||||||||||||||||||||
| Product formulations and technology | ( | ||||||||||||||||||||||
| Total | $ | $ | ( | $ | ( | $ | |||||||||||||||||
| March 31, 2024 | |||||||||||||||||||||||
| License agreements and collaboration agreements | $ | $ | ( | $ | ( | $ | |||||||||||||||||
| Customer relationships | ( | ( | |||||||||||||||||||||
| Trademarks | ( | ( | |||||||||||||||||||||
| Product formulations and technology | ( | ||||||||||||||||||||||
| Total | $ | $ | ( | $ | ( | $ | |||||||||||||||||
Amortization expense was $48.5 and $48.2 for the three months ended March 31, 2024 and 2023, respectively and $145.4 and $143.1 for the nine months ended March 31, 2024 and 2023, respectively.
8. LEASES
The Company leases office facilities under non-cancelable operating leases with terms generally ranging between 4 and 25 years. The Company utilizes these leased office facilities for use by its employees in countries in which the Company conducts its business. Leases are negotiated with third parties and, in some instances contain renewal, expansion and termination options. The Company also subleases certain office facilities to third parties when the Company no longer intends to utilize the space. None of the Company’s leases restricts the payment of dividends or the incurrence of debt or additional lease obligations, or contain significant purchase options.
16
| Three Months Ended March 31, | Nine Months Ended March 31, | ||||||||||||||||||||||
| Lease Cost: | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||
| Operating lease cost | $ | $ | $ | $ | |||||||||||||||||||
| Short-term lease cost | |||||||||||||||||||||||
| Variable lease cost | |||||||||||||||||||||||
| Sublease income | ( | ( | ( | ( | |||||||||||||||||||
| Net lease cost | $ | $ | $ | $ | |||||||||||||||||||
| Other information: | |||||||||||||||||||||||
| Operating cash outflows from operating leases | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
| Right-of-use assets obtained in exchange for lease obligations | $ | ( | $ | $ | $ | ||||||||||||||||||
| Weighted-average remaining lease term - real estate | |||||||||||||||||||||||
| Weighted-average discount rate - real estate leases | % | % | |||||||||||||||||||||
Future minimum lease payments for the Company’s operating leases are as follows:
| Fiscal Year Ending June 30, | |||||
| 2024, remaining | $ | ||||
| 2025 | |||||
| 2026 | |||||
| 2027 | |||||
| 2028 | |||||
| Thereafter | |||||
| Total future lease payments | |||||
| Less: imputed interest | ( | ||||
| Total present value of lease liabilities | |||||
| Current operating lease liabilities | |||||
| Long-term operating lease liabilities | |||||
| Total operating lease liabilities | $ | ||||
Table excludes obligations for leases with original terms of twelve months or less, which have not been recognized as right-of-use assets or liabilities in the Condensed Consolidated Balance Sheets. | |||||
17
9. DEBT
The Company’s debt balances consisted of the following as of March 31, 2024 and June 30, 2023, respectively:
| March 31, 2024 | June 30, 2023 | ||||||||||
| Short-term debt | $ | $ | |||||||||
| Senior Secured Notes | |||||||||||
| 2026 Dollar Senior Secured Notes due April 2026 | |||||||||||
| 2026 Euro Senior Secured Notes due April 2026 | |||||||||||
| 2028 Euro Senior Secured Notes due September 2028 | |||||||||||
| 2029 Dollar Senior Secured Notes due January 2029 | |||||||||||
| 2030 Dollar Senior Secured Notes due July 2030 | |||||||||||
| 2018 Coty Credit Agreement | |||||||||||
| 2023 Coty Revolving Credit Facility due July 2028 | |||||||||||
| 2021 Coty Revolving Credit Facility due April 2025 | |||||||||||
| 2018 Coty Term B Facility due April 2025 | |||||||||||
| Senior Unsecured Notes | |||||||||||
| 2026 Dollar Notes due April 2026 | |||||||||||
| 2026 Euro Notes due April 2026 | |||||||||||
| Brazilian Credit Facilities | |||||||||||
| Finance lease obligations | |||||||||||
| Total debt | |||||||||||
| Less: Short-term debt and current portion of long-term debt | ( | ( | |||||||||
| Total Long-term debt | |||||||||||
| Less: Unamortized financing fees and discounts on long-term debt | ( | ( | |||||||||
| Total Long-term debt, net | $ | $ | |||||||||
Short-Term Debt
The Company maintains short-term lines of credit and other short-term debt with financial institutions around the world. As of March 31, 2024, total short-term debt increased by $1.5 from nil as of June 30, 2023. In addition, the Company had undrawn letters of credit of $4.1 and $7.2 , and bank guarantees of $21.1 and $16.3 as of March 31, 2024 and June 30, 2023, respectively.
Long-Term Debt
Recent Developments
Cash Tender Offers
On December 7, 2023, the Company completed its previously announced cash tender offers and redeemed $150.0 of the Company's 2026 Dollar Notes (as defined below) and $250.0 of the Company's 2026 Dollar Senior Secured Notes (as defined below).
Refinancing Amendment
On July 11, 2023, the Company entered into an amendment to the 2018 Coty Credit Agreement that (i) refinanced all of the existing $2,000.0 of revolving credit commitments and the outstanding loans made pursuant thereto (the "2021 Coty Revolving Credit Facility") with two new tranches of senior secured revolving credit commitments, one in an aggregate principal amount of $1,670.0 available in U.S. dollars and certain other currencies and the other in an aggregate principal amount of €300.0 million available in euros, maturing in July 2028 (together, the "2023 Coty Revolving Credit Facility"), (ii) provided for a credit spread adjustment of 0.10 % for all interest periods, with respect to Secured Overnight Financing Rate ("SOFR") loans,
18
(iii) added Fitch as a relevant rating agency for purposes of the collateral release provisions and determining applicable interest rates and fees and (iv) provided that certain covenants will cease to apply during a collateral release period.
Offering of Senior Secured Notes
On July 26, 2023, the Company issued an aggregate principal amount of $750.0 of 6.625 % senior secured notes due 2030 (“2030 Dollar Senior Secured Notes”). Coty received net proceeds of $740.6 in connection with the offering of the 2030 Dollar Senior Secured Notes. In accordance with the 2018 Coty Credit Agreement (as defined below), as amended, the net proceeds received from this offering were utilized to pay down the outstanding balance of the U.S. dollar and euro portions of the 2018 Coty Term B Facility, as defined below, by $715.5 and €22.6 million (approximately $25.1 ), respectively, in addition to related fees and expenses thereto.
On September 19, 2023, the Company issued an aggregate principal amount of €500.0 million of 5.750 % senior secured notes due 2028 ("2028 Euro Senior Secured Notes") in a private offering. Coty received net proceeds of €493.8 million in connection with the offering of the 2028 Euro Senior Secured Notes. In accordance with the 2018 Coty Credit Agreement (as defined below), as amended, the net proceeds received from this offering were utilized to pay down a portion of the borrowings outstanding under the 2023 Coty Revolving Credit Facility, without a reduction in commitment. Coty used cash on hand to pay the related fees and expenses to this offering.
2018 Term B Facility Repayment
On August 3, 2023, the Company repaid €408.0 million (approximately $446.1 ) of the debt outstanding under the 2018 Term B Facility.
Paydown of Brazilian Credit Facility
On October 5, 2023, a wholly-owned subsidiary of the Company utilized cash on hand to fully paid down the U.S. Dollar-denominated credit facility in Brazil in the amount of $31.9 .
Senior Secured Notes
On April 21, 2021, the Company issued an aggregate principal amount of $900.0 of 5.00 % senior secured notes due 2026 (the “2026 Dollar Senior Secured Notes”). Coty received gross proceeds of $900.0 in connection with the offering of the 2026 Dollar Senior Secured Notes.
On June 16, 2021, the Company issued an aggregate principal amount of €700.0 million of 3.875 % senior secured notes due 2026 (the “2026 Euro Senior Secured Notes”) in a private offering. Coty received gross proceeds of €700.0 million in connection with the offering of the 2026 Euro Senior Secured Notes.
On November 30, 2021, the Company issued an aggregate principal amount of $500.0 of 4.75 % senior secured notes due 2029 ("2029 Dollar Senior Secured Notes" and, together with the 2026 Euro Senior Secured Notes, 2028 Euro Senior Secured Notes, 2029 Dollar Senior Secured Notes and 2030 Dollar Senior Secured Notes, the “Senior Secured Notes”). Coty received gross proceeds of $500.0 in connection with the offering of the 2029 Dollar Senior Secured Notes.
See the above Recent Developments section for the issuances of the 2028 Euro Senior Secured Notes and 2030 Dollar Senior Secured Notes.
Coty used the gross proceeds of the offerings of the Senior Secured Notes to repay a portion of the term loans outstanding under the existing credit facilities and to pay related fees and expenses thereto.
The Senior Secured Notes are senior secured obligations of Coty and are guaranteed on a senior secured basis by each of Coty’s wholly-owned domestic subsidiaries that guarantees Coty’s obligations under its existing senior secured credit facilities and are secured by first priority liens on the same collateral that secures Coty’s obligations under its existing senior secured credit facilities, as described above. The Senior Secured Notes and the guarantees are equal in right of payment with all of Coty’s and the guarantors’ respective existing and future senior indebtedness and are pari passu with all of Coty’s and the guarantors’ respective existing and future indebtedness that is secured by a first priority lien on the collateral, including the existing senior secured credit facilities, to the extent of the value of such collateral. For the 2028 Euro Senior Secured Notes and the 2030 Dollar Senior Secured Notes, the collateral security and certain covenants will be released upon the respective Senior Secured Notes achieving investment grade ratings from two out of the three ratings agencies.
Optional Redemption
Applicable Premium
The indentures governing the Senior Secured Notes specify the Applicable Premium (as defined in the respective indentures) to be paid upon early redemption of some or all of the Senior Secured Notes prior to, and on or after, April 15, 2023 for the 2026 Euro Senior Secured Notes and 2026 Dollar Senior Secured Notes, September 15, 2025 for the 2028 Euro Senior
19
Secured Notes, January 15, 2025 for the 2029 Dollar Senior Secured Notes and July 15, 2026 for the 2030 Dollar Senior Secured Notes (the "Early Redemption Dates").
The Applicable Premium related to the respective Senior Secured Notes on any redemption date and as calculated by the Company is the greater of:
(1)1.0
(2)the excess, if any, of (a) the present value at such redemption date of (i) the redemption price of such respective Senior Secured Notes that would apply if such respective notes were redeemed on the respective Early Redemption Dates, (such redemption price is expressed as a percentage of the principal amount being set forth in the table appearing in the Redemption Pricing section below), plus (ii) all remaining scheduled payments of interest due on the respective Senior Secured Notes to and including the respective Early Redemption Dates, (excluding accrued but unpaid interest, if any, to, but excluding, the redemption date), with respect to each of subclause (i) and (ii), computed using a discount rate equal to the Treasury Rate in the case of the 2026 Dollar Senior Secured Notes, 2029 Dollar Senior Secured Notes and 2030 Dollar Senior Secured Notes, or Bund Rate in the case of the 2026 Euro Senior Secured Notes and the 2028 Euro Senior Secured Notes (both Treasury Rate and Bund Rate as defined in the respective indentures) as of such redemption date plus 50
Redemption Pricing
At any time and from time to time prior to the Early Redemption Dates, the Company may redeem some or all of the respective notes at redemption prices equal to 100
At any time on or after the Early Redemption Dates, the Company may redeem some or all of the respective notes at the redemption prices (expressed in percentage of principal amount) set forth below, plus accrued and unpaid interest, if any, to, but excluding, the redemption dates, if redeemed during the twelve-month period beginning on respective dates of each of the years indicated below:
| Price | |||||||||||||||||||||||||||||
| For the period beginning | 2026 Dollar Senior Secured Notes | 2026 Euro Senior Secured Notes | 2028 Euro Senior Secured Notes | 2029 Dollar Senior Secured Notes | 2030 Dollar Senior Secured Notes | ||||||||||||||||||||||||
| Year | April 15, | September 15, | January 15, | July 15, | |||||||||||||||||||||||||
| 2024 | N/A | N/A | N/A | ||||||||||||||||||||||||||
| 2025 | N/A | ||||||||||||||||||||||||||||
| 2026 | N/A | N/A | |||||||||||||||||||||||||||
| 2027 | N/A | N/A | |||||||||||||||||||||||||||
| 2028 and thereafter | N/A | N/A | |||||||||||||||||||||||||||
2018 Coty Credit Agreement
On April 5, 2018, the Company entered into an amended and restated credit agreement (the "2018 Coty Credit Agreement"), which, as previously disclosed, was amended most recently in July 2023.
As amended and restated through July 2023, the 2018 Coty Credit Agreement provides for (a) the incurrence by the Company of (1) a senior secured term A facility in an aggregate principal amount of (i) $1,000.0 denominated in U.S. dollars and (ii) €2,035.0 million denominated in euros (the “2018 Coty Term A Facility”) and (2) a senior secured term B facility in an aggregate principal amount of (i) $1,400.0 denominated in U.S. dollars and (ii) €850.0 million denominated in euros (the “2018 Coty Term B Facility”) and (b) the incurrence by the Company and Coty B.V., a Dutch subsidiary of the Company (the “Dutch Borrower” and, together with the Company, the “Borrowers”), of the 2023 Coty Revolving Credit Facility (together with the 2018 Coty Term A Facility and the 2018 Coty Term B Facility, the "Coty Credit Facilities"). See the above Recent Developments section for information on the revolver refinancing made in July 2023.
The 2018 Coty Credit Agreement, as amended, provides that with respect to the 2023 Coty Revolving Credit Facility, up to $150.0 is available for letters of credit and up to $150.0 is available for swing line loans. The 2018 Coty Credit Agreement, as amended, also permits, subject to certain terms and conditions, the incurrence of incremental facilities thereunder in an aggregate amount of (i) $1,700.0 plus (ii) an unlimited amount if the First Lien Net Leverage Ratio (as defined in the 2018 Coty Credit Agreement, as amended), at the time of incurrence of such incremental facilities and after giving effect thereto on a pro forma basis, is less than or equal to 3.00 to 1.00.
The obligations of the Company under the 2018 Coty Credit Agreement, as amended, are guaranteed by the material wholly-owned subsidiaries of the Company organized in the U.S., subject to certain exceptions (the “Guarantors”) and the
20
obligations of the Company and the Guarantors under the 2018 Coty Credit Agreement, as amended, are secured by a perfected first priority lien (subject to permitted liens) on substantially all of the assets of the Company and the Guarantors, subject to certain exceptions. The Dutch Borrower does not guarantee the obligations of the Company under the 2018 Coty Credit Agreement or grant any liens on its assets to secure any obligations under the 2018 Coty Credit Agreement.
As previously disclosed, the Company utilized proceeds from certain transactions to pay down portions of the outstanding balances of the 2018 Coty Term A Facility and 2018 Coty Term B Facility, in accordance to the 2018 Coty Credit Agreement, as amended. No balances remain outstanding under the 2018 Coty Term A Facility or 2018 Coty Term B Facility as of September 30, 2023. See the above Recent Developments section for information on the prepayments made on the 2018 Coty Term B Facility during the nine months ended March 31, 2024.
Senior Unsecured Notes
On April 5, 2018 the Company issued, at par, $550.0 of 6.50 % senior unsecured notes due 2026 (the “2026 Dollar Notes”), €550.0 million of 4.00 % senior unsecured notes due 2023 (the “2023 Euro Notes”) and €250.0 million of 4.75 % senior unsecured notes due 2026 (the “2026 Euro Notes” and, together with the 2023 Euro Notes, the “Euro Notes,” and the Euro Notes together with the 2026 Dollar Notes, the “Senior Unsecured Notes”) in a private offering.
The Senior Unsecured Notes are senior unsecured debt obligations of the Company and will be pari passu in right of payment with all of the Company’s existing and future senior indebtedness (including the Coty Credit Facilities). The Senior Unsecured Notes are guaranteed, jointly and severally, on a senior basis by the Guarantors. The Senior Unsecured Notes are senior unsecured obligations of the Company and are effectively junior to all existing and future secured indebtedness of the Company to the extent of the value of the collateral securing such secured indebtedness. The related guarantees are senior unsecured obligations of each Guarantor and are effectively junior to all existing and future secured indebtedness of such Guarantor to the extent of the value of the collateral securing such indebtedness.
The 2026 Dollar and Euro Notes will mature on April 15, 2026. The 2026 Dollar Notes will bear interest at a rate of 6.50 % per annum. The 2026 Euro Notes will bear interest at a rate of 4.75 % per annum. Interest on the 2026 Dollar and Euro Notes is payable semi-annually in arrears on April 15 and October 15 of each year.
The Company redeemed the 2023 Euro Notes on April 15, 2022. On December 7, 2022, the Company redeemed $77.0 of the 2026 Dollar Notes and €69.7 million (approximately $72.2 ) of the 2026 Euro Notes.
Upon the occurrence of certain change of control triggering events with respect to a series of Senior Unsecured Notes, the Company will be required to offer to repurchase all or part of the Senior Unsecured Notes of such series at 101 % of their principal amount, plus accrued and unpaid interest, if any, to, but excluding, the purchase date applicable to such Senior Unsecured Notes.
The Senior Unsecured Notes contain customary covenants that place restrictions in certain circumstances on, among other things, incurrence of liens, entry into sale or leaseback transactions, sales of all or substantially all of the Company’s assets and certain merger or consolidation transactions. The Senior Unsecured Notes also provide for customary events of default.
Deferred Financing Costs
The Company wrote off unamortized deferred issuance fees and discounts of $0.0 and $0.0 during the three months ended March 31, 2024 and 2023, respectively, and $7.4 and $0.8 during the nine months ended March 31, 2024 and 2023, respectively, which were recorded in Other expense (income), net in the Condensed Consolidated Statement of Operations. Additionally, the Company capitalized deferred issuance fees of $0.0 and $0.0 during the three months ended March 31, 2024 and 2023, respectively and $40.4 and $0.0 during the nine months ended March 31, 2024 and 2023.
Interest
The 2018 Coty Credit Agreement facilities will bear interest at rates equal to, at the Company’s option, either:
(1)SOFR of the applicable qualified currency, of which the Company can elect the applicable one, two, three, six or twelve month rate, plus the applicable margin; or
(2)Alternate base rate (“ABR”) plus the applicable margin.
21
In the case of the 2023 Coty Revolving Credit Facility, the applicable margin means the lesser of a percentage per annum to be determined in accordance with the leverage-based pricing grid and the debt rating-based grid below:
| Pricing Tier | Total Net Leverage Ratio: | SOFR plus: | Alternative Base Rate Margin: | |||||||||||||||||
| 1.0 | Greater than or equal to | |||||||||||||||||||
| 2.0 | Less than | |||||||||||||||||||
| 3.0 | Less than | |||||||||||||||||||
| 4.0 | Less than | |||||||||||||||||||
| 5.0 | Less than | |||||||||||||||||||
| 6.0 | Less than | |||||||||||||||||||
| Pricing Tier | Debt Ratings (S&P/Fitch/Moody’s): | SOFR plus: | Alternative Base Rate Margin: | |||||||||||||||||
| 5.0 | Less than BB+/Ba1 | |||||||||||||||||||
| 4.0 | BB+/Ba1 | |||||||||||||||||||
| 3.0 | BBB-/Baa3 | |||||||||||||||||||
| 2.0 | BBB/Baa2 | |||||||||||||||||||
| 1.0 | BBB+/Baa1 or higher | |||||||||||||||||||
Fair Value of Debt
| March 31, 2024 | June 30, 2023 | ||||||||||||||||||||||
| Carrying Amount | Fair Value | Carrying Amount | Fair Value | ||||||||||||||||||||
| Senior Secured Notes | $ | $ | $ | $ | |||||||||||||||||||
| 2018 Coty Credit Agreement | |||||||||||||||||||||||
| Senior Unsecured Notes | |||||||||||||||||||||||
| Brazilian Credit Facilities | |||||||||||||||||||||||
The fair value of the 2023 Coty Revolving Credit Facility is equal to its carrying value, as the Company has the ability to repay the outstanding principal at par value at any time. The Company uses the market approach to value its other debt instruments. The Company obtains fair values from independent pricing services or utilizes the U.S. dollar SOFR curve to determine the fair value of these debt instruments. Based on the assumptions used to value these liabilities at fair value, these debt instruments are categorized as Level 2 in the fair value hierarchy.
Debt Maturities Schedule
Aggregate maturities of the Company’s long-term debt, including the current portion of long-term debt and excluding short-term debt and finance lease obligations as of March 31, 2024, are presented below:
| Fiscal Year Ending June 30, | |||||
| 2024, remaining | |||||
| 2025 | |||||
| 2026 | |||||
| 2027 | |||||
| 2028 | |||||
| Thereafter | |||||
| Total | $ | ||||
Covenants
The 2018 Coty Credit Agreement contains affirmative and negative covenants. The negative covenants include, among other things, limitations on debt, liens, dispositions, investments, fundamental changes, restricted payments and affiliate
22
transactions. With certain exceptions as described below, the 2018 Coty Credit Agreement, as amended, includes a financial covenant that requires us to maintain a Total Net Leverage Ratio (as defined below), equal to or less than the ratios shown below for each respective test period.
| Quarterly Test Period Ending | Total Net Leverage Ratio (a) | ||||||||||
March 31, 2024 through July 11, 2028 | |||||||||||
(a) Total Net Leverage Ratio means, as of any date of determination, the ratio of: (a) (i) Total Indebtedness minus (ii) unrestricted and Cash Equivalents of the Parent Borrower and its Restricted Subsidiaries as determined in accordance with GAAP to (b) Adjusted EBITDA for the most recently ended Test Period (each of the defined terms, including Adjusted EBITDA, used within the definition of Total Net Leverage Ratio have the meanings ascribed to them within the 2018 Coty Credit Agreement, as amended). Adjusted EBITDA, as defined in the 2018 Coty Credit Agreement, as amended, includes certain add backs related to cost savings, unusual events such as COVID-19, operating expense reductions and future unrealized synergies subject to certain limits and conditions as specified in the 2018 Coty Credit Agreement, as amended.
In the four fiscal quarters following the closing of any Material Acquisition (as defined in the 2018 Coty Credit Agreement, as amended), including the fiscal quarter in which such Material Acquisition occurs, the maximum Total Net Leverage Ratio shall be the lesser of (i) 5.95 to 1.00 and (ii) 1.00 higher than the otherwise applicable maximum Total Net Leverage Ratio for such quarter (as set forth in the table above). Immediately after any such four fiscal quarter period, there shall be at least two consecutive fiscal quarters during which the Company's Total Net Leverage Ratio is no greater than the maximum Total Net Leverage Ratio that would otherwise have been required in the absence of such Material Acquisition, regardless of whether any additional Material Acquisitions are consummated during such period.
As of March 31, 2024, the Company was in compliance with all covenants contained within the 2018 Coty Credit Agreement, as amended.
10. INTEREST EXPENSE, NET
Interest expense, net for the three and nine months ended March 31, 2024 and 2023, respectively, is presented below:
| Three Months Ended March 31, | Nine Months Ended March 31, | ||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
| Interest expense | $ | $ | $ | $ | |||||||||||||||||||
| Foreign exchange losses (gains), net of derivative contracts | ( | ||||||||||||||||||||||
| Interest income | ( | ( | ( | ( | |||||||||||||||||||
| Total interest expense, net | $ | $ | $ | $ | |||||||||||||||||||
23
11. EMPLOYEE BENEFIT PLANS
The components of net periodic benefit cost for pension plans and other post-employment benefit plans recognized in the Condensed Consolidated Statements of Operations are presented below:
| Three Months Ended March 31, | |||||||||||||||||||||||||||||||||||||||||||||||
| Pension Plans | Other Post- Employment Benefits | ||||||||||||||||||||||||||||||||||||||||||||||
| U.S. | International | Total | |||||||||||||||||||||||||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||||||||||||||||||||||
| Service cost | |||||||||||||||||||||||||||||||||||||||||||||||
| Interest cost | |||||||||||||||||||||||||||||||||||||||||||||||
| Expected return on plan assets | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||
| Amortization of prior service credit | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||
| Amortization of net (gain) loss | ( | ( | ( | ( | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||
| Net periodic benefit cost (credit) | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||
| Nine Months Ended March 31, | |||||||||||||||||||||||||||||||||||||||||||||||
| Pension Plans | Other Post- Employment Benefits | ||||||||||||||||||||||||||||||||||||||||||||||
| U.S. | International | Total | |||||||||||||||||||||||||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||||||||||||||||||||||
| Service cost | |||||||||||||||||||||||||||||||||||||||||||||||
| Interest cost | |||||||||||||||||||||||||||||||||||||||||||||||
| Expected return on plan assets | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||
| Amortization of prior service credit | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||
| Amortization of net (gain) loss | ( | ( | ( | ( | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||
| Net periodic benefit cost (credit) | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||
12. DERIVATIVE INSTRUMENTS
Foreign Exchange Risk
The Company is exposed to foreign currency exchange fluctuations through its global operations. The Company may reduce its exposure to fluctuations in the cash flows associated with changes in foreign exchange rates by creating offsetting positions through the use of derivative instruments and also by designating foreign currency denominated borrowings and cross-currency swaps as hedges of net investments in foreign subsidiaries. The Company expects that through hedging, any gain or loss on the derivative instruments would generally offset the expected increase or decrease in the value of the underlying forecasted transactions.
As of March 31, 2024 and June 30, 2023, the notional amount of the outstanding forward foreign exchange contracts designated as cash flow hedges were $19.7 and $28.0 , respectively.
The Company also uses certain derivatives not designated as hedging instruments consisting primarily of foreign currency forward contracts and cross-currency swaps to hedge intercompany transactions and foreign currency denominated external debt. Although these derivatives were not designated for hedge accounting, the overall objective of mitigating foreign currency exposure is the same for all derivative instruments. For derivatives not designated as hedging instruments, changes in fair value are recorded in the line item in the Condensed Consolidated Statements of Operations to which the derivative relates. As of March 31, 2024 and June 30, 2023, the notional amounts of these outstanding non-designated foreign currency forward and cross-currency swap contracts were $1,627.6 and $1,653.5 , respectively.
Interest Rate Risk
24
As of June 30, 2023, the Company had interest rate swap contracts in the notional amount of $200.0 , which were fully terminated in December 2023 for a cash receipt of $2.1 . As the forecasted interest expense under the original swap agreements is still probable, the related gain in accumulated other comprehensive income (loss) ("AOCI/L") will be amortized over the remaining life of the swaps. These interest rate swaps had been designated and qualified as cash flow hedges and were highly effective prior to termination.
Net Investment Hedge
Foreign currency gains and losses on borrowings designated as a net investment hedge, except ineffective portions, are reported in the cumulative translation adjustment (“CTA”) component of AOCI/(L), along with the foreign currency translation adjustments on those investments. As of March 31, 2024 and June 30, 2023, the nominal exposures of foreign currency denominated borrowings designated as net investment hedges were €1,113.5 million and €701.3 million, respectively. The designated hedge amounts were considered highly effective.
Forward Repurchase Contracts
In June 2022, December 2022, and November 2023, the Company entered into certain forward repurchase contracts to start hedging for potential $200.0 , $196.0 , and $294.0 share buyback programs, in 2024, 2025, and 2026, respectively. These forward repurchase contracts are accounted for at fair value, with changes in the fair value recorded in Other expense (income), net in the Condensed Consolidated Statements of Operations.
In February 2024, the Company elected to physically settle the June 2022 Forward for a cash payment of $200.0 in exchange for 27.0 million shares of its Class A Common Stock. Refer to Note 13—Equity and Convertible Preferred Stock.
Derivative and non-derivative financial instruments which are designated as hedging instruments:
The accumulated loss on foreign currency borrowings classified as net investment hedges in the foreign currency translation adjustment component of AOCI/(L) was $0.0 and $(12.2 ) as of March 31, 2024 and June 30, 2023, respectively.
In September 2020, the Company terminated its net investment cross-currency swap derivative with a notional amount of $550.0 in exchange for a cash payment of $37.6 . The loss related to this termination of $(37.6
The amount of gains and losses recognized in Other comprehensive income (loss) (“OCI”) in the Condensed Consolidated Balance Sheets related to the Company’s derivative and non-derivative financial instruments which are designated as hedging instruments is presented below:
| Gain (Loss) Recognized in OCI | Three Months Ended March 31, | Nine Months Ended March 31, | |||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
| Foreign exchange forward contracts | $ | $ | ( | $ | $ | ( | |||||||||||||||||
| Interest rate swap contracts | ( | ( | |||||||||||||||||||||
| Net investment hedges | ( | ( | |||||||||||||||||||||
The accumulated gain on derivative instruments classified as cash flow hedges in AOCI/(L), net of tax, was $1.2 and $0.7 as of March 31, 2024 and June 30, 2023, respectively. The estimated net gain related to these effective hedges that is expected to be reclassified from AOCI/(L) into earnings within the next twelve months is $1.1 . As of March 31, 2024, all of the Company's remaining foreign currency forward contracts designated as hedges were highly effective.
25
| Location and Amount of Gain (Loss) Recognized in Income on Cash Flow Hedging Relationships | Three Months Ended March 31, | ||||||||||||||||||||||||||||||||||
| 2024 | 2023 | ||||||||||||||||||||||||||||||||||
| Cost of sales | Interest expense, net | Cost of sales | Interest expense, net | ||||||||||||||||||||||||||||||||
| Foreign exchange forward contracts: | |||||||||||||||||||||||||||||||||||
| Amount of gain (loss) reclassified from AOCI into income | $ | ( | $ | $ | $ | ||||||||||||||||||||||||||||||
| Interest rate swap contracts: | |||||||||||||||||||||||||||||||||||
| Amount of gain (loss) reclassified from AOCI into income | |||||||||||||||||||||||||||||||||||
| Location and Amount of Gain (Loss) Recognized in Income on Cash Flow Hedging Relationships | Nine Months Ended March 31, | ||||||||||||||||||||||||||||||||||
| 2024 | 2023 | ||||||||||||||||||||||||||||||||||
| Cost of sales | Interest expense, net | Cost of sales | Interest expense, net | ||||||||||||||||||||||||||||||||
| Foreign exchange forward contracts: | |||||||||||||||||||||||||||||||||||
| Amount of gain (loss) reclassified from AOCI into income | $ | ( | $ | $ | ( | $ | |||||||||||||||||||||||||||||
| Interest rate swap contracts: | |||||||||||||||||||||||||||||||||||
| Amount of gain (loss) reclassified from AOCI into income | |||||||||||||||||||||||||||||||||||
Derivatives not designated as hedging:
The amount of gains and losses related to the Company’s derivative financial instruments not designated as hedging instruments is presented below:
| Condensed Consolidated Statements of Operations Classification of Gain (Loss) Recognized in Operations | Three Months Ended March 31, | Nine Months Ended March 31, | ||||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||||||
| Foreign exchange contracts | Selling, general and administrative expenses | $ | $ | ( | $ | ( | $ | ( | ||||||||||||||||||
| Foreign exchange contracts | Interest expense, net | ( | ( | ( | ||||||||||||||||||||||
| Foreign exchange and forward repurchase contracts | Other income, net | ( | ( | |||||||||||||||||||||||
13. EQUITY AND CONVERTIBLE PREFERRED STOCK
Common Stock
As of March 31, 2024, the Company’s common stock consisted of Class A Common Stock with a par value of $0.01 per share. The holders of Class A Common Stock are entitled to one vote per share. As of March 31, 2024, total authorized shares of Class A Common Stock was 1,250.0 million and total outstanding shares of Class A Common Stock was 867.9 million.
On September 29, 2023 and October 2, 2023, the Company issued a total of 33.0 million shares of Class A common stock, par value $0.01 per share, at a public offering price of $10.80 (or €10.28 ) per share in a global offering (the “Offering”). The Company also announced the admission to listing and trading of its Common Stock on the professional segment of the Euronext Paris.
The Company received $348.4 from the Offering, net of $10.0 of underwriting fees. Additionally, the Company incurred $6.0 in other professional fees. The underwriting fees and other professional fees incurred in connection with the Offering were incremental costs directly attributable to the issuance and thus were presented as a reduction of Equity in the Condensed Consolidated Balance Sheets.
The Company's Majority Stockholder
As of March 31, 2024 JAB Beauty B.V. ("JAB"), the Company’s largest stockholder, may be deemed to beneficially own approximately 55 % of Coty’s Class A Common Stock. This is inclusive of all voting interests of Mr. Peter Harf, the Company's
26
Chairman, and HFS Holdings S.à r.l, (“HFS”), which is beneficially owned by Mr. Harf, including its shares of Series B Preferred Stock on an if converted basis.
The Company’s CEO, Sue Nabi, was granted a one-time sign-on award of restricted stock units on June 30, 2021. On October 29, 2021 and September 18, 2023, JAB completed the transfer of 10.0 million and 5.0 million shares of Common Stock, respectively, to Ms. Nabi pursuant to an equity transfer agreement. See Note 14—Share-Based Compensation Plans for additional information.
Series A and A-1 Preferred Stock
As of March 31, 2024, total authorized shares of preferred stock are 20.0 million. There are two classes of Preferred Stock, Series A Preferred Stock and Series A-1 Preferred Stock, both with a par value of $0.01
Pursuant to the Series A Preferred Stock subscription agreement dated March 27, 2017, as the holder did not exchange the vested Series A Preferred Stock by the specified expiration date, the Company has the right to redeem the Series A Preferred Stock (1.0 million shares) at a redemption price of $0.01 per share. The Company plans to redeem these shares of Series A Preferred Stock in accordance with their terms.
As of March 31, 2024, there were 1.0 no no
As of March 31, 2024, the Company has $0.0 Series A Preferred Stock classified as a liability recorded in Accrued expenses and other current liabilities in the Condensed Consolidated Balance Sheet.
Convertible Series B Preferred Stock
On May 11, 2020, the Company entered into an Investment Agreement with KKR Rainbow Aggregator L.P. ("KKR Aggregator"), relating to the issuance and sale by the Company to KKR Aggregator of up to 1,000,000 shares of the Company’s new Convertible Series B Preferred Stock, par value $0.01 per share (the “Series B Preferred Stock”), for an aggregate purchase price of up to $1,000.0 , or $1,000 per share (the “Issuance”). The Company completed the issuances and sales of the Series B Preferred Stock on May 26, 2020 and July 31, 2020. On November 16, 2020, KKR Aggregator and affiliated investment funds agreed to sell 146,057 shares of Series B Preferred Stock, to HFS. The transaction closed on August 27, 2021.
As a result of various conversions and exchanges of KKR Aggregator's shares of the Series B Preferred Stock, as of December 31, 2021, Kohlberg Kravis Roberts & Co. L.P. and its affiliates ("KKR") has fully redeemed/exchanged all of their Series B Preferred Stock.
Cumulative preferred dividends accrue daily on the Series B Preferred Stock at a rate of 9.0 % per year. During the three months ended March 31, 2024 and 2023, the Board of Directors declared dividends on the Series B Preferred Stock of $3.3 3.3 9.9 9.9 3.3
Treasury Stock
Share Repurchase Program
Since February 2014, the Board has authorized the Company to repurchase its Class A Common Stock under approved repurchase programs. On February 3, 2016, the Board authorized the Company to repurchase up to $500.0 of its Class A Common Stock, and on November 13, 2023, the Board increased the Company's share repurchase authorization by an additional $600.0 (the “Share Repurchase Program”). Repurchases may be made from time to time at the Company’s discretion, based on ongoing assessments of the capital needs of the business, the market price of its Class A Common Stock, and general market conditions. As of March 31, 2024, the Company had authority for $796.8 remaining under the Share Repurchase Program.
In June 2022, December 2022 and November 2023, the Company entered into forward repurchase contracts (the “Forward” and together the “Forwards”) with three large financial institutions (“Counterparties”) to start hedging for potential $200.0 , $196.0 and $294.0 share buyback programs in 2024, 2025 and 2026, respectively.
In February 2024, the Company elected to physically settle the June 2022 Forward for a cash payment of $200.0 in exchange for 27.0 million shares of its Class A Common Stock. The fair value of the shares repurchased was approximately $350.6 , which was recorded as an increase to Treasury stock in the Condensed Consolidated Balance Sheets and Condensed Consolidated Statements of Equity.
As part of the Forward agreements, the Company will pay interest on the outstanding underlying notional amount of the Forwards held by the Counterparties during the contract periods. The interest rates are variable, based on the United States
27
secured overnight funding rate (“SOFR”) plus a spread. The weighted average interest rate plus applicable spread for the December 2022 and November 2023 Forward transactions were 9.8 % and 8.2 %, respectively, as of March 31, 2024.
Since the Forwards permit a net cash settlement alternative in addition to the physical settlement, the Company accounted for the Forwards initially and subsequently at their fair value, with changes in the fair value recorded in Other expense (income), net in the Condensed Consolidated Statement of Operations. See Note 12—Derivative Instruments for additional information.
Dividends
On April 29, 2020, the Board of Directors suspended the payment of dividends on Common Stock. No dividends on Common Stock were declared for the period ended March 31, 2024.
The change in dividends accrued recorded to APIC in the Condensed Consolidated Balance Sheet as of March 31, 2024 and 2023 was nil and $0.1 , respectively, which represent dividends no longer expected to vest as a result of forfeitures of outstanding restricted stock units (“RSUs”). In addition, the Company made payments of $0.3 and $0.7 , of which $0.1 and $0.2 related to employee taxes, for the previously accrued dividends on RSUs that vested during the nine months ended March 31, 2024 and 2023, respectively.
Total accrued dividends on unvested RSUs and phantom units included in Accrued expenses and other current liabilities are $0.8 and $1.0 as of March 31, 2024 and June 30, 2023, respectively. In addition, accrued dividends of $0.0 and $0.1 are included in Other noncurrent liabilities as of March 31, 2024 and June 30, 2023, respectively.
Accumulated Other Comprehensive Income (Loss)
| Foreign Currency Translation Adjustments | |||||||||||||||||||||||||||||
| Gain on Cash Flow Hedges | (Loss) gain on Net Investment Hedge | Other Foreign Currency Translation Adjustments | Pension and Other Post-Employment Benefit Plans (a) | Total | |||||||||||||||||||||||||
| Balance—July 1, 2023 | $ | $ | ( | $ | ( | $ | $ | ( | |||||||||||||||||||||
| Other comprehensive income (loss) before reclassifications | ( | ( | ( | ||||||||||||||||||||||||||
| Net amounts reclassified from AOCI/(L) | ( | ( | |||||||||||||||||||||||||||
| Net current-period other comprehensive income (loss) | ( | ( | ( | ||||||||||||||||||||||||||
| Balance—March 31, 2024 | $ | $ | ( | $ | ( | $ | $ | ( | |||||||||||||||||||||
(a) For the nine months ended March 31, 2024, other comprehensive loss before reclassifications of $0.6 and net amounts reclassified from AOCI/(L) related to pensions and other post-employment benefit plans included amortization of prior service credits and actuarial losses of $4.5 , net of tax of $1.4 .
| Foreign Currency Translation Adjustments | |||||||||||||||||||||||||||||
| Loss on Cash Flow Hedges | Gain (loss) on Net Investment Hedge | Other Foreign Currency Translation Adjustments | Pension and Other Post-Employment Benefit Plans | Total | |||||||||||||||||||||||||
| Balance—July 1, 2022 | $ | $ | $ | ( | $ | $ | ( | ||||||||||||||||||||||
| Other comprehensive income (loss) before reclassifications | ( | ||||||||||||||||||||||||||||
| Net amounts reclassified from AOCI/(L) | ( | ( | ( | ||||||||||||||||||||||||||
| Net current-period other comprehensive (loss) income | ( | ( | ( | ||||||||||||||||||||||||||
| Balance—March 31, 2023 | $ | ( | $ | ( | $ | ( | $ | $ | ( | ||||||||||||||||||||
28
14. SHARE-BASED COMPENSATION PLANS
Share-based compensation expense is recognized on a straight-line basis over the requisite service period. Total share-based compensation is shown in the table below:
| Three Months Ended March 31, | Nine Months Ended March 31, | ||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Equity plan expense (a) | $ | $ | $ | $ | |||||||||||||||||||
| Liability plan (income) expense | |||||||||||||||||||||||
| Fringe expense | ( | ||||||||||||||||||||||
| Total share-based compensation expense | $ | $ | $ | $ | |||||||||||||||||||
(a) Equity plan share-based compensation expense was recorded to additional paid in capital and presented in the Condensed Consolidated Statements of Equity.
As of March 31, 2024, the total unrecognized share-based compensation expense related to stock options, restricted stock, restricted stock units and other share awards, and performance restricted stock units ("PRSUs") is $0.1 , $0.0 , $149.5 , and $31.1 , respectively. The unrecognized share-based compensation expense related to stock options, restricted stock, restricted stock units and other share awards, and PRSUs, is expected to be recognized over a weighted-average period of 0.62 , 0.00 , 3.44 and 2.37 years, respectively.
Restricted Stock Units and Other Share Awards
The Company granted nil and 4.5 million shares of RSUs and other share awards during the three and nine months ended March 31, 2024. The Company recognized share-based compensation expense of $15.0 and $31.5 for the three months ended March 31, 2024 and 2023, respectively, of which $5.1 and $23.0 related to Ms. Nabi's award, as described below. The Company recognized share-based compensation expense of $63.7 and $96.3 for the nine months ended March 31, 2024 and 2023, respectively, of which $31.3 and $70.1 related to Ms. Nabi's award.
Performance Restricted Stock Units
The Company granted nil and 3.7 million shares of PRSUs, during the three and nine months ended March 31, 2024. The Company recognized share-based compensation expense of $3.3 and $0.6 for the three months ended March 31, 2024 and 2023, respectively, of which $1.8 and $0.0 related to Ms. Nabi's award, as described below. The Company recognized share-based compensation expense of $7.1 and $1.0 for the nine months ended March 31, 2024 and 2023, respectively, of which $3.6 and $0.0 related to Ms. Nabi's award, as described below.
Long-term Equity Program for CEO
The Company’s CEO, Sue Nabi, was granted a one-time sign-on award of restricted stock units (the “Award”) on June 30, 2021. The Award vested and settled in 10.0 0.01
In connection with this Award, on October 29, 2021 and September 18, 2023, JAB, the Company’s largest stockholder and a wholly-owned subsidiary of JAB Holding Company S.à r.l., completed the transfer of 10.0 million and 5.0 million shares of Class A Common Stock, respectively, to Ms. Nabi.
On August 31, 2023 and 2022, the Company issued 5.0 million and 10.0 million shares of Class A Common Stock, respectively, to Ms. Nabi in connection with the third and second vesting of the Award.
Pursuant to the term of the amended employment agreement on May 4, 2023, the Company granted Ms. Nabi a one-time award of 10,416,667 RSUs and will grant a total of 10,416,665 PRSUs in five equal tranches over the next five years . These two awards will vest periodically over the next seven years in accordance with the terms discussed below.
Ms. Nabi's 10,416,667 RSUs will vest and settle in shares of the Company’s Class A Common Stock, par value $0.01 per share over five years on the following vesting schedule: (i) 15 % on September 1, 2024, (ii) 15 % on September 1, 2025, (iii) 20 % on September 1, 2026, (iv) 20 % on September 1, 2027; and (v) 30 % on September 1, 2028, in each case subject to Ms. Nabi’s continued employment through the applicable vesting date. The Company will recognize approximately $109.6 of share-based compensation expense, on a straight-line basis over the vesting period, based on the fair value on the grant date, net of forfeitures. The amount of compensation cost recognized at each vesting date must at least equal the portion of the award legally vested.
29
The first tranche of Ms. Nabi's PRSU award of 2,083,333 shares shall fully vest on September 1, 2026, subject to the achievement of three-year performance objectives determined by the Board on September 28, 2023 (the grant date) and subject to Ms. Nabi’s continued employment. The next four tranches of 2,083,333 PRSUs will be granted on or around each September 1 of 2024 through 2027, which shall vest on the third-year anniversary of the respective grant date, subject in each case to the achievement of three-year performance objectives to be determined by the Board. The Company will recognize share-based compensation expense associated with these PRSUs, on a straight-line basis over the vesting period, based on the fair value on the grant date when it is probable that the performance condition will be achieved.
In the event that JAB and Ms. Nabi sell shares of Common Stock for cash in a privately negotiated transaction, subject to Board approval, the Company will grant Ms. Nabi new options to acquire shares of Common Stock (the “Reload Options”) in an amount equal to the number of shares sold by Ms. Nabi in such transaction. The Reload Options will have a strike price equal to the greater of the volume weighted average price for shares at the time of the relevant transaction and the fair market value on the date of grant. The potential expense attributed to the reload options will be recognized when the reload options are granted.
Restricted Stock
The Company granted nil and 0.3 million shares of restricted stock, during the three and nine months ended March 31, 2024. The Company recognized share-based compensation expense of $2.0 and $0.7 for the three months ended March 31, 2024 and 2023, respectively, and $3.1 and $1.9 for the nine months ended March 31, 2024 and 2023, respectively. Due to significant executive forfeitures, 0.5 million shares of restricted stock were cancelled and reclassified as Treasury Stock.
Series A Preferred Stock and Series A-1 Preferred Stock
The Company granted no 0.1 ) and $0.6 for the three months ended March 31, 2024 and 2023, respectively, and $(0.8 ) and $0.4 for the nine months ended March 31, 2024 and 2023, respectively.
Non-Qualified Stock Options
The Company granted no 0.2 and $0.2 for the three months ended March 31, 2024 and 2023, respectively, and $0.3 and $0.8 for the nine months ended March 31, 2024 and 2023, respectively.
30
15. NET INCOME ATTRIBUTABLE TO COTY INC. PER COMMON SHARE
Reconciliation between the numerators and denominators of the basic and diluted income per share (“EPS”) computations is presented below:
| Three Months Ended March 31, | Nine Months Ended March 31, | ||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
| Amounts attributable to Coty Inc.: | |||||||||||||||||||||||
| Net income attributable to Coty Inc. | $ | $ | $ | $ | |||||||||||||||||||
| Convertible Series B Preferred Stock dividends | ( | ( | ( | ( | |||||||||||||||||||
| Net income attributable to common stockholders | $ | $ | $ | $ | |||||||||||||||||||
Weighted-average common shares outstanding: | |||||||||||||||||||||||
| Weighted-average common shares outstanding—Basic | |||||||||||||||||||||||
Effect of dilutive stock options and Series A Preferred Stock (a) | |||||||||||||||||||||||
Effect of restricted stock and RSUs (b) | |||||||||||||||||||||||
Effect of Convertible Series B Preferred Stock (c) | |||||||||||||||||||||||
Effect of Forward Repurchase Contracts (d) | |||||||||||||||||||||||
| Weighted-average common shares outstanding—Diluted | |||||||||||||||||||||||
| Earnings per common share: | |||||||||||||||||||||||
| Earnings per common share - basic | $ | $ | $ | $ | |||||||||||||||||||
Earnings per common share - diluted (e) | |||||||||||||||||||||||
(a) For the three months ended March 31, 2024 and 2023, outstanding stock options and Series A Preferred Stock with purchase or conversion rights to purchase 1.7 million and 5.6 million shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS. For the nine months ended March 31, 2024 and 2023, outstanding stock options and Series A Preferred Stock with purchase or conversion rights to purchase 2.5 million and 5.8 million weighted average shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS.
(b) For the three months ended March 31, 2024 and 2023, there were nil 1.3 million and nil weighted average anti-dilutive RSUs, respectively, excluded from the computation of diluted EPS.
(c) For the three months ended March 31, 2024 and 2023 and the nine months ended March 31, 2024 there were 23.7
(d) For the three and nine months ended March 31, 2024 and 2023, respectively, shares for the Forward Repurchase Contracts were excluded from the computation of diluted EPS as Coty is in the position to receive shares from the counterparties and as such their inclusion would be anti-dilutive.
(e) Diluted EPS is adjusted by the effect of dilutive securities, including awards under the Company's equity compensation plans, the convertible Series B Preferred Stock, and the Forward Repurchase Contracts. When calculating any potential dilutive effect of stock options, Series A Preferred Stock, restricted stock, RSUs and PRSUs, the Company uses the treasury method and the if-converted method for the Convertible Series B Preferred Stock and the Forward Repurchase Contracts. The treasury method typically does not adjust the net income attributable to Coty Inc., while the if-converted method requires an adjustment to reverse the impact of the preferred stock dividends of $3.3 and $3.3 , respectively, and to reverse the impact of fair market value losses/(gains) for contracts with the option to settle in shares or cash of $7.1 and $(93.9 ), respectively, if dilutive, for the three months ended March 31, 2024 and 2023 on net income applicable to common stockholders during the period. The if-converted method requires an adjustment to reverse the impact of the preferred stock dividends of $9.9 and $9.9 , respectively, and to reverse the impact of fair market value losses/(gains) for contracts with the option to settle in shares or cash of $6.9 and $(100.7 ), respectively, if dilutive, for the nine months ended March 31, 2024 and 2023 on net income applicable to common stockholders during the period.
31
16. REDEEMABLE NONCONTROLLING INTERESTS
Subsidiary in the Middle East
As of March 31, 2024, the noncontrolling interest holder in the Company’s subsidiary in the Middle East had a 25 % ownership share. The Company adjusts the redeemable noncontrolling interests (“RNCI”) to redemption value at the end of each reporting period with changes recognized as adjustments to APIC. The Company recognized $94.2 and $93.5 as the RNCI balances as of March 31, 2024 and June 30, 2023, respectively.
17. COMMITMENTS AND CONTINGENCIES
Legal Matters
The Company is involved, from time to time, in various litigation, administrative and other legal proceedings, including regulatory actions, incidental or related to its business, including consumer class or collective actions, personal injury (mostly involving allegations related to alleged asbestos in the Company’s talc-based cosmetic products), intellectual property, competition, compliance and advertising claims litigation and disputes, among others (collectively, “Legal Proceedings”). While the Company cannot predict any final outcomes relating thereto, management believes that the outcome of current Legal Proceedings will not have a material effect upon its business, prospects, financial condition, results of operations, cash flows or the trading price of the Company’s securities. However, management’s assessment of the Company’s current Legal Proceedings is ongoing, and could change in light of the discovery of additional facts with respect to Legal Proceedings not presently known to the Company, further legal analysis, or determinations by judges, arbitrators, juries or other finders of fact or deciders of law which are not in accord with management’s evaluation of the probable liability or outcome of such Legal Proceedings. From time to time, the Company is in discussions with regulators, including discussions initiated by the Company, about actual or potential violations of law in order to remediate or mitigate associated legal or compliance risks and liabilities or penalties. As the outcomes of such proceedings are unpredictable, the Company can give no assurance that the results of any such proceedings will not materially affect its reputation, business, prospects, financial condition, results of operations, cash flows or the trading price of its securities.
Brazilian Tax Assessments
The Company’s Brazilian subsidiaries receive tax assessments from local, state and federal tax authorities in Brazil from time to time. Current open tax assessments as of March 31, 2024 are:
| Assessment received | Type of assessment | Type of Tax | Tax period impacted | Estimated amount, including interest and penalties as of March 31, 2024 | |||||||||||||
| Mar-18 | State sales tax credits, which the Treasury Office of the State of Goiás considers as improperly registered | ICMS | 2016-2017 | R$ | |||||||||||||
| Aug-20 | ICMS | 2017-2019 | R$ | ||||||||||||||
| Oct-20 | Federal excise taxes, which the Treasury Office of the Brazil’s Internal Revenue Service considers as improperly calculated | IPI | 2016-2017 | R$ | |||||||||||||
| Nov-22 | IPI | 2018-2019 | R$ | ||||||||||||||
| Nov-20 | State sales taxes, which the Treasury Office of the State of Minas Gerais considers as improperly calculated | ICMS | 2016-2019 | R$ | |||||||||||||
| Jun-21 | State sales tax, which the Treasury Office of the State of Goiás considers as improperly calculated | ICMS | 2016-2020 | R$ | |||||||||||||
(a) During the fourth quarter of fiscal 2023, the ICMS assessment received in March 2018 had an unfavorable decision at administrative instance. The Company paid the R$ | |||||
The Minas Gerais State tax ICMS assessment received in November 2020 is currently at the judicial process. For the Goiás State tax ICMS assessment received in August 2020, the Company has in parallel a judicial case about an additional claim for fees over the tax incentive, for which the Company received an unfavorable ruling and has filed an appeal. In the first quarter of fiscal 2024, the Company filed a motion for clarification as a step before potentially appealing to a Brazilian higher court, which was denied. In December 2023, the Company filed appeals to be remitted to the Special and Supreme Brazilian Courts and, in parallel, filed a motion to grant the suspension of the state's ability to collect the above tax incentives to the Goiás State Court. In January 2024, the motion to grant the suspension of the state's ability to collect the above tax incentives was
32
dismissed. The case is currently awaiting judgment at the Special and Supreme Brazilian Courts. All other cases are currently in the administrative process. The Company expects that cases may move from the administrative to the judicial process, although the exact timing is uncertain. For cases in the judicial process, the Company will be required to make a judicial deposit or enter into a surety bond for the disputed tax assessment, interest and penalties. The judicial process in Brazil is likely to take a number of years to conclude. The Company is seeking favorable judicial and administrative decisions on the tax enforcement actions filed by the tax authorities for these assessments. The Company believes it has meritorious defenses and it has not recognized a loss for these assessments as the Company does not believe a loss is probable.
Due to the fiscal environment in Brazil, the possibility of further tax assessments related to the same or similar matters cannot be ruled out.
18. RELATED PARTY TRANSACTIONS
Wella
On December 22, 2021, the Company entered into an agreement with Rainbow UK Bidco Limited (“KKR Bidco”) (an affiliate of funds and/or separately managed accounts advised and/or managed by KKR), related to post-closing adjustments to the purchase consideration for the Coty’s Professional and Retail Hair businesses, including the Wella, Clairol, OPI and ghd brands, (together, the “Wella Business”). In relation to this contingent consideration agreement, the Company received cash proceeds of $6.0 during the three months ended March 31, 2024. The Company also recognized a gain of $1.4 and $9.9 , in the three and nine months ended March 31, 2024, and $2.1 and $28.5 , in the three and nine months ended March 31, 2023, respectively, which is reported in Other expense (income), net in the Condensed Consolidated Statements of Operations.
As of March 31, 2024, Coty owned 25.84 % of the Wella Company as an equity investment and performs certain services to Wella. Refer to Note 6— Equity Investments.
In connection with the sale of the Wella Business, the Company and Wella entered into a Transitional Services Agreement (“TSA”) and the Company performed services for Wella in exchange for related service fees. The Company and Wella have mutually agreed to end the contracted TSA services on January 31, 2022, as well as previously existing distribution services in Brazil during the third quarter of fiscal 2024. The Company and Wella continue to have in place manufacturing arrangements to facilitate the Wella Business transition in the U.S. and Brazil. TSA fees and other fees earned were $0.4 and $4.8 , respectively, for the three months ended March 31, 2024 and $0.9 and $1.8 , respectively, for the three months ended March 31, 2023. TSA fees and other fees earned were $2.2 and $9.8 , respectively, for the nine months ended March 31, 2024 and $2.4 and $5.9 , respectively, for the nine months ended March 31, 2023. Fees are principally invoiced on a cost plus basis and were included in Selling, general and administrative expenses and Cost of sales, respectively, in the Company's Condensed Consolidated Statement of Operations.
The Company also entered into an agreement with Wella to provide management, consulting and financial services. The Company earned $0.3 and $0.9 in the three and nine months ended March 31, 2024, respectively, and $0.3 and $0.8 in the three and nine months ended March 31, 2023, respectively, which are reflected in Other expense (income), net in the Condensed Consolidated Statements of Operations.
As of March 31, 2024, accounts receivable from and accounts payable to Wella of $53.1 and $20.0 , respectively, were included in Prepaid expenses and other current assets and Accrued expenses and other current liabilities, respectively, in the Company's Condensed Consolidated Balance Sheets. Additionally, as of March 31, 2024, the Company has accrued $33.9 related to long-term payables due to Wella included in Other noncurrent liabilities in the Company's Condensed Consolidated Balance Sheet.
Coty will continue to recognize the share-based compensation expense for Wella employees until the existing equity awards reach their vesting date. For the three and nine months ended March 31, 2024 and 2023, Coty recorded $0.5 and $1.1 , respectively, and $1.8 and $3.8 , respectively, of share-based compensation expense related to Wella employees, which was presented as part of Other expense (income), net in the Condensed Consolidated Statements of Operations.
The Company has certain sublease arrangements with Wella after the sale. The Company reported sublease income from Wella of $2.1 and $2.3 , respectively, and $6.2 and $7.0 , respectively, for the three and nine months ended March 31, 2024 and 2023.
19. SUBSEQUENT EVENTS
The Company evaluated the effect of events and transactions subsequent to the condensed consolidated balance sheet date of March 31, 2024 through the date of issuance of the Condensed Consolidated Financial Statements and determined that no subsequent events have occurred that require recognition in the Condensed Consolidated Financial Statements or disclosure in the notes to the Condensed Consolidated Financial Statements.
33
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
The following discussion and analysis of the financial condition and results of operations of Coty Inc. and its consolidated subsidiaries, should be read in conjunction with the information contained in the Condensed Consolidated Financial Statements and related notes included elsewhere in this document, and in our other public filings with the Securities and Exchange Commission (“SEC”), including our Annual Report on Form 10-K for the fiscal year ended June 30, 2023 (“Fiscal 2023 Form 10-K”). When used in this discussion, the terms “Coty,” the “Company,” “we,” “our,” or “us” mean, unless the context otherwise indicates, Coty Inc. and its majority and wholly-owned subsidiaries. Also, when used in this Quarterly Report on Form 10-Q, the term “includes” and “including” means, unless the context otherwise indicates, including without limitation. The following report includes certain non-GAAP financial measures. See “Overview—Non-GAAP Financial Measures” for a discussion of non-GAAP financial measures and how they are calculated.
All dollar amounts in the following discussion are in millions of United States (“U.S.”) dollars, unless otherwise indicated.
More information about potential risks and uncertainties that could affect our business and financial results is included under the heading “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in this Quarterly Report on Form 10-Q and other periodic reports we have filed and may file with the SEC from time to time.
Forward-looking Statements
Certain statements in this Form 10-Q are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect our current views with respect to, among other things, strategic planning, targets and outlook for future reporting periods (including the extent and timing of revenue, expense and profit trends and changes in operating cash flows and cash flows from operating activities and investing activities), the Company’s future operations and strategy (including the expected implementation and related impact of its strategic priorities), ongoing and future cost efficiency, optimization and restructuring initiatives and programs, expectations of the impact of inflationary pressures and the timing, magnitude and impact of pricing actions to offset inflationary costs, strategic transactions (including their expected timing and impact), expectations and/or plans with respect to joint ventures (including Wella and the timing and size of any related divestiture, distribution or return of capital), the Company’s capital allocation strategy and payment of dividends (including suspension of dividend payments and the duration thereof and any plans to resume cash dividends on common stock or to continue to pay dividends in cash on preferred stock) and expectations for stock repurchases, investments, licenses and portfolio changes, product launches, relaunches or rebranding (including the expected timing or impact thereof), synergies, savings, performance, cost, timing and integration of acquisitions, future cash flows, liquidity and borrowing capacity (including any refinancing or deleveraging activities), timing and size of cash outflows and debt deleveraging, the timing and extent of any future impairments, and synergies, savings, impact, cost, timing and implementation of the Company’s ongoing strategic transformation agenda (including operational and organizational structure changes, operational execution and simplification initiatives, fixed cost reductions, continued process improvements and supply chain changes), the impact, cost, timing and implementation of e-commerce and digital initiatives, the expected impact, cost, timing and implementation of sustainability initiatives (including progress, plans, goals and our ability to achieve sustainability targets), the wind down of the Company’s operations in Russia (including timing and expected impact), the impact of public health events, the expected impact of geopolitical risks including the ongoing war in Ukraine and/or the armed conflict in the Middle East (including the Red Sea conflict) on our business operations, sales outlook and strategy, the expected impact of global supply chain challenges and/or inflationary pressures (including as a result of the war in Ukraine and/or armed conflict in the Middle East including the Red Sea conflict) and expectations regarding future service levels and inventory levels, the impact of the dual-listing of our Class A Common Stock on Euronext Paris, and the priorities of senior management. These forward-looking statements are generally identified by words or phrases, such as “anticipate”, “are going to”, “estimate”, “plan”, “project”, “expect”, “believe”, “intend”, “foresee”, “forecast”, “will”, “may”, “should”, “outlook”, “continue”, “temporary”, “target”, “aim”, “potential”, “goal” and similar words or phrases. These statements are based on certain assumptions and estimates that we consider reasonable, but are subject to a number of risks and uncertainties, many of which are beyond our control, which could cause actual events or results (including our financial condition, results of operations, cash flows and prospects) to differ materially from such statements, including risks and uncertainties relating to:
•our ability to successfully implement our multi-year strategic transformation agenda and compete effectively in the beauty industry, achieve the benefits contemplated by our strategic initiatives (including revenue growth, cost control, gross margin growth and debt deleveraging) and successfully implement our strategic priorities (including stabilizing our consumer beauty brands through leading innovation and improved execution, accelerating our prestige fragrance brands and ongoing expansion into prestige cosmetics, building a comprehensive skincare portfolio, enhancing our e-commerce and direct-to-consumer (“DTC”) capabilities, expanding our presence in China through prestige products and select consumer beauty brands, and establishing Coty as an industry leader in sustainability) in each case within the expected time frame or at all;
•our ability to anticipate, gauge and respond to market trends and consumer preferences, which may change rapidly, and the market acceptance of new products, including new products in our skincare and prestige cosmetics portfolios, any relaunched or rebranded products and the anticipated costs and discounting associated with such relaunches and
34
rebrands, and consumer receptiveness to our current and future marketing philosophy and consumer engagement activities (including digital marketing and media), and our ability to effectively manage our production and inventory levels in response to demand;
•use of estimates and assumptions in preparing our financial statements, including with regard to revenue recognition, income taxes (including the expected timing and amount of the release of any tax valuation allowance), the assessment of goodwill, other intangible and long-lived assets for impairments, the market value of inventory, and the fair value of the equity investment;
•the impact of any future impairments;
•managerial, transformational, operational, regulatory, legal and financial risks, including diversion of management attention to and management of cash flows, expenses and costs associated with our transformation agenda, our global business strategies, the integration and management of our strategic partnerships, and future strategic initiatives, and, in particular, our ability to manage and execute many initiatives simultaneously including any resulting complexity, employee attrition or diversion of resources;
•the timing, costs and impacts of divestitures and the amount and use of proceeds from any such transactions;
•future divestitures and the impact thereof on, and future acquisitions, new licenses and joint ventures and the integration thereof with, our business, operations, systems, financial data and culture and the ability to realize synergies, manage supply chain challenges and other business disruptions, reduce costs (including through our cash efficiency initiatives), avoid liabilities and realize potential efficiencies and benefits (including through our restructuring initiatives) at the levels and at the costs and within the time frames contemplated or at all;
•increased competition, consolidation among retailers, shifts in consumers’ preferred distribution and marketing channels (including to digital and prestige channels), distribution and shelf-space resets or reductions, compression of go-to-market cycles, changes in product and marketing requirements by retailers, reductions in retailer inventory levels and order lead-times or changes in purchasing patterns, impact from COVID-19 or similar public health events on retail revenues, and other changes in the retail, e-commerce and wholesale environment in which we do business and sell our products and our ability to respond to such changes (including our ability to expand our digital, direct-to-consumer and e-commerce capabilities within contemplated timeframes or at all);
•our and our joint ventures’, business partners’ and licensors’ abilities to obtain, maintain and protect the intellectual property used in our and their respective businesses, protect our and their respective reputations (including those of our and their executives or influencers) and public goodwill, and defend claims by third parties for infringement of intellectual property rights;
•any change to our capital allocation and/or cash management priorities, including any change in our dividend policy and any change in our stock repurchase plans;
•any unanticipated problems, liabilities or integration or other challenges associated with a past or future acquired business, joint ventures or strategic partnerships, which could result in increased risk or new, unanticipated or unknown liabilities, including with respect to environmental, competition and other regulatory, compliance or legal matters, and specifically in connection with the strategic partnerships with Kylie Jenner and Kim Kardashian, risks related to the entry into a new distribution channel, the potential for channel conflict, risks of retaining customers and key employees, difficulties of integration (or the risks associated with limiting integration) and management of the partnerships, our relationships with Kylie Jenner and Kim Kardashian, our ability to protect trademarks and brand names, litigation, investigations by governmental authorities, and changes in law, regulations and policies that affect King Kylie LLC (“King Kylie”) and/or KKW Holdings, LLC’s (“KKW Holdings”) business or products, including risk that direct selling laws and regulations may be modified, interpreted or enforced in a manner that results in a negative impact to King Kylie and/or KKW Holdings’ business model, revenue, sales force or business;
•our international operations and joint ventures, including enforceability and effectiveness of our joint venture agreements and reputational, compliance, regulatory, economic and foreign political risks, including difficulties and costs associated with maintaining compliance with a broad variety of complex local and international regulations;
•our dependence on certain licenses (especially in the fragrance category) and our ability to renew expiring licenses on favorable terms or at all;
•our dependence on entities performing outsourced functions, including outsourcing of distribution functions, and third-party manufacturers, logistics and supply chain suppliers, and other suppliers, including third-party software providers, web-hosting and e-commerce providers;
35
•administrative, product development and other difficulties in meeting the expected timing of market expansions, product launches, re-launches and marketing efforts, including in connection with new products in our skincare and prestige cosmetics portfolios;
•changes in the demand for our products due to declining or depressed global or regional economic conditions, and declines in consumer confidence or spending, whether related to the economy (such as austerity measures, tax increases, high fuel costs, or higher unemployment), wars and other hostilities and armed conflicts, natural or other disasters, weather, pandemics, security concerns, terrorist attacks or other factors;
•global political and/or economic uncertainties, disruptions or major regulatory or policy changes, and/or the enforcement thereof that affect our business, financial performance, operations or products, including the impact of the war in Ukraine and any escalation or expansion thereof, armed conflict in the Middle East, the current U.S. administration and future elections, changes in the U.S. tax code and/or tax regulations in other jurisdictions where we operate (including recent and pending implementation of the global minimum corporate tax (part of the “Pillar Two Model Rules”) that may impact our tax liability in the European Union (“EU”)), and recent changes and future changes in tariffs, retaliatory or trade protection measures, trade policies and other international trade regulations in the U.S., the EU, and Asia and in other regions where we operate, potential regulatory limits on payment terms in the EU, future changes in sanctions regulations, regulatory uncertainty impacting the wind-down of our business in Russia, recent and future changes in regulations impacting the beauty industry, including regulatory measures addressing products, formulations, raw materials and packaging, and recent and future regulatory measures restricting or otherwise impacting the use of web sites, mobile applications or social media platforms that we use in connection with our digital marketing and e-commerce activities;
•currency exchange rate volatility and currency devaluation and/or inflation;
•our ability to implement and maintain pricing actions to effectively mitigate increased costs and inflationary pressures, and the reaction of customers or consumers to such pricing actions;
•the number, type, outcomes (by judgment, order or settlement) and costs of current or future legal, compliance, tax, regulatory or administrative proceedings, investigations and/or litigation, including product liability cases (including asbestos and talc-related litigation for which indemnities and/or insurance may not be available), distributor or licensor litigation, and compliance, litigation or investigations relating to our joint ventures or strategic partnerships;
•our ability to manage seasonal factors and other variability and to anticipate future business trends and needs;
•disruptions in the availability and distribution of raw materials and components needed to manufacture our products, and our ability to effectively manage our production and inventory levels in response to supply challenges;
•disruptions in operations, sales and in other areas, including due to disruptions in our supply chain, restructurings and other business alignment activities, manufacturing or information technology systems, labor disputes, extreme weather and natural disasters, impact from public health events, the outbreak of war or hostilities (including the war in Ukraine and armed conflict in the Middle East, including the Red Sea conflict, and any escalation or expansion thereof), the impact of global supply chain challenges or other disruptions in the international flow of goods, and the impact of such disruptions on our ability to generate profits, stabilize or grow revenues or cash flows, comply with our contractual obligations and accurately forecast demand and supply needs and/or future results;
•our ability to adapt our business to address climate change concerns, including through the implementation of new or unproven technologies or processes, and to respond to increasing governmental and regulatory measures relating to environmental, social and governance matters, including expanding mandatory and voluntary reporting, diligence and disclosure, as well as new taxes (including on energy and plastic), new diligence requirements and the impact of such measures or processes on our costs, business operations and strategy;
•restrictions imposed on us through our license agreements, credit facilities and senior unsecured bonds or other material contracts, our ability to generate cash flow to repay, refinance or recapitalize debt and otherwise comply with our debt instruments, and changes in the manner in which we finance our debt and future capital needs;
•increasing dependency on information technology, including as a result of remote working practices, and our ability or the ability of any of the third-party service providers we use to support our business, to protect against service interruptions, data corruption, cyber-based attacks or network security breaches, including ransomware attacks, costs and timing of implementation and effectiveness of any upgrades or other changes to information technology systems, and the cost of compliance or our failure to comply with any privacy or data security laws (including the European Union General Data Protection Regulation (the “GDPR”), the California Consumer Privacy Act and similar state laws, the Brazil General Data Protection Law, and the China Data Security Law and Personal Information Protection Law) or to protect against theft of customer, employee and corporate sensitive information;
•our ability to attract and retain key personnel and the impact of senior management transitions;
36
•the distribution and sale by third parties of counterfeit and/or gray market versions of our products;
•the impact of our ongoing strategic transformation agenda and continued process improvements on our relationships with key customers and suppliers and certain material contracts;
•our relationship with JAB Beauty B.V., as our majority stockholder, and its affiliates, and any related conflicts of interest or litigation;
•our relationship with KKR, whose affiliate KKR Bidco, is an investor in the Wella Business, and any related conflicts of interest or litigation;
•future sales of a significant number of shares by our majority stockholder or the perception that such sales could occur; and
•other factors described elsewhere in this document and in documents that we file with the SEC from time to time.
More information about potential risks and uncertainties that could affect our business and financial results is included under the heading “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in this Quarterly Report on Form 10-Q and other periodic reports we have filed and may file with the SEC from time to time.
All forward-looking statements made in this document are qualified by these cautionary statements. These forward-looking statements are made only as of the date of this document, and we do not undertake any obligation, other than as may be required by applicable law, to update or revise any forward-looking or cautionary statements to reflect changes in assumptions, the occurrence of events, unanticipated or otherwise, or changes in future operating results over time or otherwise.
Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance unless expressed as such, and should only be viewed as historical data.
Industry, Ranking and Market Data
Unless otherwise indicated, information contained in this Quarterly Report on Form 10-Q concerning our industry and the markets in which we operate, including our general expectations about our industry, market position, market opportunity and market sizes, is based on data from various sources including internal data and estimates as well as third-party sources widely available to the public, such as independent industry publications, government publications, reports by market research firms or other published independent sources and on our assumptions based on that data and other similar sources. We did not fund and are not otherwise affiliated with the third-party sources that we cite. Industry publications and other published sources generally state that the information contained therein has been obtained from third-party sources believed to be reliable. Internal data and estimates are based upon information obtained from trade and business organizations and other contacts in the markets in which we operate and management’s understanding of industry conditions, and such information has not been verified by any independent sources. These data involve a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates. While we generally believe the market, industry and other information included in this Quarterly Report on Form 10-Q to be the most recently available and to be reliable, such information is inherently imprecise and we have not independently verified any third-party information or verified that more recent information is not available.
Our fiscal year ends on June 30. Unless otherwise noted, any reference to a year preceded by the word “fiscal” refers to the fiscal year ended June 30 of that year. For example, references to “fiscal 2024” refer to the fiscal year ending June 30, 2024. Any reference to a year not preceded by “fiscal” refers to a calendar year.
OVERVIEW
We are one of the world’s largest beauty companies, with an iconic portfolio of brands across fragrance, color cosmetics, and skin and body care. Our brands empower people to express themselves freely, creating their own visions of beauty; and we are committed to making a positive impact on the planet. Our strategic priorities include stabilizing and growing our Consumer Beauty brands through leading innovation and improved execution, accelerating our Prestige fragrance business and ongoing expansion into Prestige cosmetics, building a comprehensive skincare portfolio over the mid-to-long term leveraging existing brands, enhancing our organizational growth capabilities including digital and research and development, expanding our presence in China, the Travel Retail channel and growth markets, and establishing Coty as an industry leader in sustainability.
37
We have been making progress on our strategic priorities. In Consumer Beauty, we have implemented the relaunch of our top brands and returned to stable growth and steady margin improvement. We are now focusing on accelerating our digital advocacy strategy to amplify our brand and product innovations and leveraging consumer analytics and insights to improve the return on investment of our marketing activities. In Prestige, we continue to accelerate the fragrance business with exceptional new launches and expansion in premium and ultra-premium categories, while steadily expanding the distribution, productivity and assortment of our Prestige cosmetics. We are continuing to thoughtfully expand our skincare portfolio, with our focus on winning over the most discerning skin care consumers in our areas of excellence – UV protection and photoaging prevention and repair, biotech-enhanced longevity science, and micro-dose formulations. We have successfully expanded our e-commerce capabilities, through best-in-class online launches, our digital advocacy strategy and active participation in key online shopping events, and increasing digital media competitiveness.
Our products are sold in over 120 countries and territories. As a geographically diverse company we are susceptible to global economic trends, geopolitical conflicts, domestic and foreign governmental policies, and changes in foreign exchange rates. In particular, economic conditions in China have had, and are expected to continue to have, an impact on our strategic initiatives, including our growth agenda in the region for Prestige products and our skincare growth priorities. Within the China market we continue to monitor and take actions to address the impact to our Consumer Beauty brands which have experienced sales declines as retailers and distributors continue to deplete their existing inventory. In addition, as the conflict in the Red Sea continues to develop, we have implemented alternate transport routes and have purchased safety stock to mitigate impacts on the flow of goods. We remain attentive to economic and geopolitical conditions that may materially impact our business. We continue to explore and implement risk mitigation strategies in the face of these unfolding conditions and remain agile in adapting to changing circumstances. Such conditions have or may have global implications which may impact the future performance of our business in unpredictable ways.
Changing market trends may impact sales of our products across and within product categories and regions. Within our Consumer Beauty segment, positive market trends within the skin and body care and mass color cosmetics categories in Brazil positively impacted the segment's sales volume during the third quarter. Excluding the contribution from the Brazilian brands, the Consumer Beauty segment experienced a decline in sales volume primarily in the skin and body care category, as a result of a decline in sales from China, and in the color cosmetic category, due to negative market trends in the U.S. in mass color cosmetics market.
We expect that our net revenue for fiscal year 2024 will grow in the high single digits to low double digits versus the prior year, excluding the impact of foreign exchange, the Russia Market Exit and the early termination of the Lacoste fragrance license. We anticipate that our annual gross margin will remain in the mid-sixties, providing us with opportunities to fund new product initiatives and support our brands through advertising and consumer promotional investments. We continue to target advertising and consumer promotional spending in the high-twenties percentage of net revenues. However, our level of advertising and consumer promotional spending will depend on various factors, including seasonality, the timing of product launches, and budgetary considerations. We anticipate that fixed costs as a percentage of our net revenues will incrementally improve annually as we continue to take steps to gradually optimize our fixed cost base.
Order Fill Rates
Our ability to fulfill demand for our products is critical to our success. Through steps taken to improve order fill rates and mitigate the impact of supply chain constraints, we have seen sequential quarterly improvements in our order fill rates on a company-wide basis. As a result, beginning in the second quarter we achieved close to pre-COVID-19 service levels across our divisions.
Inflation
Inflationary trends in certain markets and global supply chain challenges may negatively affect our sales and operating performance. The impact of inflation on material, logistical and other costs subsided during the nine months ended March 31, 2024, which was primarily driven by a significant easing during the second and third quarters. Inflation may continue to impact certain costs, such as labor, however, we currently anticipate the overall impact of inflation to remain muted in the fourth quarter of fiscal 2024.
38
Non-GAAP Financial Measures
To supplement the financial measures prepared in accordance with GAAP, we use non-GAAP financial measures for continuing operations and Coty Inc. including Adjusted operating income (loss), Adjusted EBITDA, Adjusted net income (loss), and Adjusted net income (loss) attributable to Coty Inc. to common stockholders (collectively, the “Adjusted Performance Measures”). The reconciliations of these non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are shown in tables below. These non-GAAP financial measures should not be considered in isolation from, or as a substitute for or superior to, financial measures reported in accordance with GAAP. Moreover, these non-GAAP financial measures have limitations in that they do not reflect all the items associated with the operations of the business as determined in accordance with GAAP. Other companies, including companies in the beauty industry, may calculate similarly titled non-GAAP financial measures differently than we do, limiting the usefulness of those measures for comparative purposes.
Despite the limitations of these non-GAAP financial measures, our management uses the Adjusted Performance Measures as key metrics in the evaluation of our performance and annual budgets and to benchmark performance of our business against our competitors. The following are examples of how these Adjusted Performance Measures are utilized by our management:
•strategic plans and annual budgets are prepared using the Adjusted Performance Measures;
•senior management receives a monthly analysis comparing budget to actual operating results that is prepared using the Adjusted Performance Measures; and
•senior management’s annual compensation is calculated, in part, by using some of the Adjusted Performance Measures.
In addition, our financial covenant compliance calculations under our debt agreements are substantially derived from these Adjusted Performance Measures.
Our management believes that Adjusted Performance Measures are useful to investors in their assessment of our operating performance and the valuation of the Company. In addition, these non-GAAP financial measures address questions we routinely receive from analysts and investors and, in order to ensure that all investors have access to the same data, our management has determined that it is appropriate to make this data available to all investors. The Adjusted Performance Measures exclude the impact of certain items (as further described below) and provide supplemental information regarding our operating performance. By disclosing these non-GAAP financial measures, our management intends to provide investors with a supplemental comparison of our operating results and trends for the periods presented. Our management believes these measures are also useful to investors as such measures allow investors to evaluate our performance using the same metrics that our management uses to evaluate past performance and prospects for future performance. We provide disclosure of the effects of these non-GAAP financial measures by presenting the corresponding measure prepared in conformity with GAAP in our financial statements, and by providing a reconciliation to the corresponding GAAP measure so that investors may understand the adjustments made in arriving at the non-GAAP financial measures and use the information to perform their own analyses.
Adjusted operating income/Adjusted EBITDA from continuing operations excludes restructuring costs and business structure realignment programs, amortization, acquisition- and divestiture-related costs and acquisition accounting impacts, stock-based compensation, and asset impairment charges and other adjustments as described below. For adjusted EBITDA, in addition to the preceding, we exclude adjusted depreciation as defined below. We do not consider these items to be reflective of our core operating performance due to the variability of such items from period-to-period in terms of size, nature and significance. They are primarily incurred to realign our operating structure and integrate new acquisitions, and implement divestitures of components of our business, and fluctuate based on specific facts and circumstances. Additionally, Adjusted net income attributable to Coty Inc. and Adjusted net income attributable to Coty Inc. per common share are adjusted for certain interest and other (income) expense items and preferred stock deemed dividends, as described below, and the related tax effects of each of the items used to derive Adjusted net income as such charges are not used by our management in assessing our operating performance period-to-period.
Adjusted Performance Measures reflect adjustments based on the following items:
•Costs related to acquisition and divestiture activities: We have excluded acquisition- and divestiture-related costs and the accounting impacts such as those related to transaction costs and costs associated with the revaluation of acquired inventory in connection with business combinations because these costs are unique to each transaction. Additionally, for divestitures, we exclude write-offs of assets that are no longer recoverable and contract related costs due to the divestiture. The nature and amount of such costs vary significantly based on the size and timing of the acquisitions and divestitures, and the maturities of the businesses being acquired or divested. Also, the size, complexity and/or volume of past transactions, which often drives the magnitude of such expenses, may not be indicative of the size, complexity and/or volume of any future acquisitions or divestitures.
39
•Restructuring and other business realignment costs: We have excluded costs associated with restructuring and business structure realignment programs to allow for comparable financial results to historical operations and forward-looking guidance. In addition, the nature and amount of such charges vary significantly based on the size and timing of the programs. By excluding the referenced expenses from our non-GAAP financial measures, our management is able to further evaluate our ability to utilize existing assets and estimate their long-term value. Furthermore, our management believes that the adjustment of these items supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance.
•Asset impairment charges: We have excluded the impact of asset impairments as such non-cash amounts are inconsistent in amount and frequency and are significantly impacted by the timing and/or size of acquisitions. Our management believes that the adjustment of these items supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance.
•Amortization expense: We have excluded the impact of amortization of finite-lived intangible assets, as such non-cash amounts are inconsistent in amount and frequency and are significantly impacted by the timing and/or size of acquisitions. Our management believes that the adjustment of these items supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance. Although we exclude amortization of intangible assets from our non-GAAP expenses, our management believes that it is important for investors to understand that such intangible assets contribute to revenue generation. Amortization of intangible assets that relate to past acquisitions will recur in future periods until such intangible assets have been fully amortized. Any future acquisitions may result in the amortization of additional intangible assets.
•Gain on sale and early license termination: We have excluded the impact of gain on sale and early license termination as such amounts are inconsistent in amount and frequency and are significantly impacted by the size of the sale and early license termination.
•Costs related to market exit: We have excluded the impact of direct incremental costs related to our decision to wind down our business operations in Russia. We believe that these direct and incremental costs are inconsistent and infrequent in nature. Consequently, our management believes that the adjustment of these items supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance.
•Gains on sale of real estate: We have excluded the impact of gains on sale of real estate as such amounts are inconsistent in amount and frequency and are significantly impacted by the size of the sale. Our management believes that the adjustment of these items supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance.
•Stock-based compensation: Although stock-based compensation is a key incentive offered to our employees, we have excluded the effect of these expenses from the calculation of adjusted operating income and adjusted EBITDA. This is due to their primarily non-cash nature; in addition, the amount and timing of these expenses may be highly variable and unpredictable, which may negatively affect comparability between periods.
•Depreciation and Adjusted depreciation: Our adjusted operating income excludes the impact of accelerated depreciation for certain restructuring projects that affect the expected useful lives of Property, Plant and Equipment, as such charges vary significantly based on the size and timing of the programs. Further, we have excluded adjusted depreciation, which represents depreciation expense net of accelerated depreciation charges, from our adjusted EBITDA. Our management believes that the adjustment of these items supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance.
•Other (income) expense: We have excluded the impact of pension curtailment (gains) and losses and pension settlements as such events are triggered by our restructuring and other business realignment activities and the amount of such charges vary significantly based on the size and timing of the programs. Further, we have excluded the change in fair value of the investment in Wella, as well as expenses related to potential or actual sales transactions reducing equity investments, as our management believes these unrealized (gains) and losses do not reflect our underlying ongoing business, and the adjustment of such impact helps investors and others compare and analyze performance from period to period. We have excluded the gain on the exchange of Series B Preferred Stock. Such transactions do not reflect our operating results and we have excluded the impact as our management believes that the adjustment of these items supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance.
•Noncontrolling interest: This adjustment represents the after-tax impact of the non-GAAP adjustments included in Net income attributable to noncontrolling interests based on the relevant noncontrolling interest percentage.
•Tax: This adjustment represents the impact of the tax effect of the pretax items excluded from Adjusted net income. The tax impact of the non-GAAP adjustments is based on the tax rates related to the jurisdiction in which the adjusted
40
items are received or incurred. Additionally, adjustments are made for the tax impact of any intra-entity transfer of assets and liabilities.
•Deemed Preferred Stock Dividends: We have excluded preferred stock deemed dividends related to the First Exchange and the Second Exchange (as disclosed and defined in Note 27—Related Party Transactions in our Annual Report on Form 10-K for fiscal 2023) from our calculation of adjusted net income attributable to Coty Inc. These deemed dividends are nonmonetary in nature, the transactions were entered into to simplify our capital structure and do not reflect our underlying ongoing business. Management believes that this adjustment helps investors and others compare and analyze our performance from period to period.
Constant Currency
We operate on a global basis, with the majority of our net revenues generated outside of the U.S. Accordingly, fluctuations in foreign currency exchange rates can affect our results of operations. Therefore, to supplement financial results presented in accordance with GAAP, certain financial information is presented in “constant currency”, excluding the impact of foreign currency exchange translations to provide a framework for assessing how our underlying businesses performed excluding the impact of foreign currency exchange translations. Constant currency information compares results between periods as if exchange rates had remained constant period-over-period. We calculate constant currency information by translating current and prior-period results for entities reporting in currencies other than U.S. dollars into U.S. dollars using prior year foreign currency exchange rates. The constant currency calculations do not adjust for the impact of revaluing specific transactions denominated in a currency that is different to the functional currency of that entity when exchange rates fluctuate. The constant currency information we present may not be comparable to similarly titled measures reported by other companies.
Basis of Presentation of Acquisitions, Divestitures, Terminations and Market Exit from Russia
During the period when we complete an acquisition, divestiture, early license termination, or market exit, the financial results of the current year period are not comparable to the financial results presented in the prior year period. When explaining such changes from period to period and to maintain a consistent basis between periods, we exclude the financial contribution of: (i) the acquired brands or businesses in the current year period until we have twelve months of comparable financial results, and (ii) the divested brands or businesses or early terminated brands or markets exited in the prior year period, to maintain comparable financial results with the current fiscal year period. Acquisitions, divestitures, early license terminations, and market exits that would impact the comparability of financial results between periods presented in the Management’s Discussion and Analysis of Financial Condition and Results of Operations are shown in the table below.
THREE MONTHS ENDED MARCH 31, 2024 AS COMPARED TO THREE MONTHS ENDED MARCH 31, 2023
NET REVENUES
In the three months ended March 31, 2024, net revenues increased 8%, or $96.7, to $1,385.6 from $1,288.9 in the three months ended March 31, 2023. Excluding net revenue from the third quarter of the prior period from Lacoste, net revenues increased 10% or $124.5 to $1,385.6 from $1,261.1 in the three months ended March 31, 2023, reflecting a positive price and mix impact of 6% and an increase in unit volume of 4%. The overall increase in net revenues reflects growth of prestige fragrances, specifically Burberry, as well as innovation from new launches including Marc Jacobs Daisy Wild and Cosmic Kylie Jenner, and positive performance in the prestige cosmetics category. Net revenues increased in our Consumer Beauty segment due to positive performance in the skin and body care category in Brazil, mass fragrance category, and color cosmetics category.
The overall increase in net revenues reflects the continued success of our pricing and revenue management strategies, including the implementation of targeted price increases across our product portfolio. Volume growth from certain brands in our prestige fragrance portfolio, as well as in skin and body care products in Brazil helped drive the increase in revenues. Increases were partially offset by volume declines from certain skin and body care brands in China where macroeconomic conditions have resulted in a decline in demand, and color cosmetics brands primarily in the U.S. due to negative market trends in the category.
Geographically, net revenues in all regions grew, led by the Americas. Additionally, there was an increase in the travel retail channel sales in all regions.
Digital and e-commerce channel sales growth also contributed to the increase in net revenues.
41
Net Revenues by Segment
| Three Months Ended March 31, | |||||||||||||||||
| (in millions) | 2024 | 2023 | Change % | ||||||||||||||
| NET REVENUES | |||||||||||||||||
| Prestige | $ | 867.2 | $ | 799.7 | 8 | % | |||||||||||
| Consumer Beauty | 518.4 | 489.2 | 6 | % | |||||||||||||
| Total | $ | 1,385.6 | $ | 1,288.9 | 8 | % | |||||||||||
Prestige
In the three months ended March 31, 2024, net revenues from the Prestige segment increased 8%, or $67.5 to $867.2 compared to $799.7 in the three months ended March 31, 2023. Excluding net revenue from the third quarter of the prior period from Lacoste, net revenues from the Prestige segment increased 12% or $95.3 to $867.2 from $771.9 in the three months ended March 31, 2023, reflecting a positive price and mix impact of 10% (primarily due to the positive pricing impact as a result of global price increases earlier in the fiscal year, in line with the overall premiumization strategy and brand innovation), an increase in unit volume of 3%, partially offset by a negative foreign currency exchange translation impact of 1%. The increase in net revenues primarily reflects:
•Prestige fragrance sales growth of $79.8, due to the continued success of Burberry Goddess and Burberry Hero and continued brand innovation such as Cosmic Kylie Jenner. The category sales growth can also be attributed to positive market trends as well as success in the travel retail channel; and
•Prestige cosmetic sales growth of $11.6, due to positive market trends in the prestige cosmetics category and brand innovation.
Consumer Beauty
In the three months ended March 31, 2024, net revenues from the Consumer Beauty segment increased 6%, or $29.2, to $518.4 from $489.2 in the three months ended March 31, 2023, reflecting an increase in unit volume of 4% (primarily due to Brazilian brands) and a positive price and mix impact of 2% (primarily due to price increases across the Consumer Beauty product portfolio, earlier in the fiscal year). The increase in net revenues primarily reflects:
•Skin and body care sales growth of $13.7, primarily due to the continued success of brands in Brazil led by Monange, as a result of strong category momentum and positive impact of pricing in the Brazilian market, partially offset by net revenue declines from certain brands in China due to volume declines resulting from macroeconomic trends which have negatively impacted demand resulting in a build-up of inventory at retailers and distributors; and
•Mass fragrance sales growth of $9.3, due to positive market trends and brand innovation.
Although color cosmetics net revenues grew $5.4, led by category momentum and price increases in Brazil, negative market trends primarily in the U.S. negatively impacted sales volumes, partially offsetting the overall category increase.
COST OF SALES
In the three months ended March 31, 2024, cost of sales increased 2%, or $9.7, to $487.8 from $478.1 in the three months ended March 31, 2023. Cost of sales as a percentage of net revenues decreased to 35.2% in the three months ended March 31, 2024 from 37.1% in the three months ended March 31, 2023, resulting in a gross margin increase of approximately 190 basis points, primarily reflecting:
(i)approximately 180 basis points related to a decrease in manufacturing and material costs as a percentage of net revenues, driven by increased manufacturing efficiencies, improvements in productivity, as well as procurement and material cost optimization; and
(ii)approximately 80 basis points related to decreased freight costs.
These increases were partially offset by:
(i)approximately 60 basis points related to increased excess and obsolescence costs associated with Consumer Beauty body care products in Brazil and across the Prestige product portfolio.
The above reflects a positive impact from pricing net of inflation of approximately 200 basis points.
42
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES
In the three months ended March 31, 2024, selling, general and administrative expenses increased 7%, or $50.2, to $770.6 from $720.4 in the three months ended March 31, 2023. Selling, general and administrative expenses as a percentage of net revenues decreased to 55.6% in the three months ended March 31, 2024 from 55.9% in the three months ended March 31, 2023, or approximately 30 basis points. This decrease primarily reflects:
(i)110 basis points due to a decrease in stock-based compensation cost primarily related to a reduction in expense recognized in connection with awards granted to the CEO; and
(ii)110 basis points due to favorable transactional impact from our exposure to foreign currency as a percentage of net revenues.
These decreases were partially offset by the following increases:
(i)120 basis points due to an increase in administrative costs as a percentage of net revenues due to higher compensation expense from increased headcount, partially offset by lower depreciation expense related to fully depreciated IT equipment; and
(ii)60 basis points due to an increase in advertising and consumer promotional costs primarily due to increases in in-store merchandising execution and non-working media investments.
OPERATING INCOME
In the three months ended March 31, 2024, operating income was $77.8 compared to income of $43.5 in the three months ended March 31, 2023. Operating income as a percentage of net revenues, increased to 5.6% in the three months ended March 31, 2024 as compared to 3.4% in the three months ended March 31, 2023. The increase in operating margin is primarily driven by a decrease in cost of goods sold as a percentage of net revenues (approximately 190 basis points) primarily related to a decrease in manufacturing and material costs as a percentage of net revenues and a decrease in stock compensation expense (approximately 110 basis points) primarily related to a reduction in expense recognized in connection with a prior year's grant made to the CEO, partially offset by an increase in advertising and consumer promotional costs as a percentage of revenues (approximately 60 basis points) primarily related to increased in-store merchandising execution and non-working media spend, and an increase in restructuring costs (approximately 20 basis points). In addition, the higher proportion of Consumer Beauty sales were from lower margin Brazil brands, compared to the prior year, negatively impacted our consolidated gross margin and operating income.
Operating Income (Loss) by Segment
| Three Months Ended March 31, | |||||||||||||||||
| (in millions) | 2024 | 2023 | Change % | ||||||||||||||
| Operating income (loss) | |||||||||||||||||
| Prestige | $ | 108.7 | $ | 102.4 | 6 | % | |||||||||||
| Consumer Beauty | (13.3) | (27.9) | 52 | % | |||||||||||||
| Corporate | (17.6) | (31.0) | 43 | % | |||||||||||||
| Total | $ | 77.8 | $ | 43.5 | 79 | % | |||||||||||
Prestige
In the three months ended March 31, 2024, operating income for Prestige was $108.7 compared to income of $102.4 in the three months ended March 31, 2023. Operating margin decreased to 12.5% of net revenues in the three months ended March 31, 2024 as compared to 12.8% in the three months ended March 31, 2023, driven by an increase in fixed costs as a percentage of net revenues (approximately 140 basis points) primarily related to non people-related costs and people-related costs, and an increase in advertising and consumer promotional expense as a percentage of net revenues (approximately 120 basis points) primarily related to increases in working and non-working media as a percentage of net revenues, partially offset by a decrease in cost of goods sold as a percentage of net revenues (approximately 190 basis points) primarily related to a decrease in manufacturing and material costs as a percentage of net revenues and a decrease in amortization expense as a percentage of net revenues (approximately 30 basis points).
43
Consumer Beauty
In the three months ended March 31, 2024, operating loss for Consumer Beauty was $13.3 compared to loss of $27.9 in the three months ended March 31, 2023. Operating margin increased to (2.6)% of net revenues in the three months ended March 31, 2024 as compared to (5.7)% in the three months ended March 31, 2023, driven by a decrease in transactional foreign exchange losses as a percentage of net revenues (approximately 180 basis points) primarily related to currency revaluation in Argentina in the prior year, a decrease in cost of goods sold as a percentage of net revenues (approximately 160 basis points) primarily related to a decrease in manufacturing and material costs as a percentage of net revenues, and a decrease in advertising and consumer promotional expense as a percentage of net revenues (approximately 30 basis points) primarily related to a decrease in working media, partially offset by an increase in fixed costs as a percentage of net revenues (approximately 70 basis points) primarily related to people-related costs.
Corporate
Corporate primarily includes income and expenses not directly relating to our operating activities. These items are included in Corporate since we consider them to be Corporate responsibilities, and these items are not used by our management to measure the underlying performance of the segments.
In the three months ended March 31, 2024, the operating loss for Corporate was $17.6 compared to a loss of $31.0 in the three months ended March 31, 2023, as described under “Adjusted Operating Income for Coty Inc.” below. The decrease in the operating loss for Corporate was primarily driven by a $13.2 decrease in stock compensation expense.
Adjusted Operating Income by Segment
We believe that adjusted operating income by segment further enhances an investor’s understanding of our performance. See “Overview—Non-GAAP Financial Measures.” A reconciliation of reported operating income to adjusted operating income is presented below, by segment:
| Three Months Ended March 31, 2024 | |||||||||||||||||
| (in millions) | Reported (GAAP) | Adjustments (a) | Adjusted (Non-GAAP) | ||||||||||||||
| Operating income | |||||||||||||||||
| Prestige | $ | 108.7 | $ | 38.6 | $ | 147.3 | |||||||||||
| Consumer Beauty | (13.3) | 9.9 | (3.4) | ||||||||||||||
| Corporate | (17.6) | 17.6 | — | ||||||||||||||
| Total | $ | 77.8 | $ | 66.1 | $ | 143.9 | |||||||||||
| Three Months Ended March 31, 2023 | |||||||||||||||||
| (in millions) | Reported (GAAP) | Adjustments (a) | Adjusted (Non-GAAP) | ||||||||||||||
| Operating income | |||||||||||||||||
| Prestige | $ | 102.4 | $ | 38.3 | $ | 140.7 | |||||||||||
| Consumer Beauty | (27.9) | 9.9 | (18.0) | ||||||||||||||
| Corporate | (31.0) | 31.0 | — | ||||||||||||||
| Total | $ | 43.5 | $ | 79.2 | $ | 122.7 | |||||||||||
(a)See a reconciliation of reported net income to operating income (loss) to adjusted operating income (loss) and adjusted EBITDA for Coty Inc. and reconciliations of segment operating income (loss) to segment adjusted operating income (loss) and segment adjusted EBITDA for the Prestige, Consumer Beauty and Corporate segments with a description of the adjustments under “Net Income, Adjusted Operating Income and Adjusted EBITDA for Coty Inc.” and “Segment Operating Income (Loss), Segment Adjusted Operating Income (Loss) and Segment Adjusted EBITDA”, below. All adjustments are reflected in Corporate, except for amortization and asset impairment charges on goodwill, indefinite-lived intangible assets, and finite-lived intangible assets, which are reflected in the Prestige and Consumer Beauty segments.
44
Net Income, Adjusted Operating Income and Adjusted EBITDA for Coty Inc.
We believe that adjusted operating income further enhances an investor’s understanding of our performance. See “Overview—Non-GAAP Financial Measures.” Reconciliation of reported net income to adjusted operating income and adjusted EBITDA is presented below:
| Three Months Ended March 31, | |||||||||||||||||
| (in millions) | 2024 | 2023 | Change % | ||||||||||||||
| Net income | $ | 8.8 | $ | 111.8 | (92) | % | |||||||||||
| Net income margin | 0.6 | % | 8.7 | % | |||||||||||||
| Provision (benefit) for income taxes | (5.4) | 29.8 | <(100%) | ||||||||||||||
| Income before income taxes | $ | 3.4 | $ | 141.6 | (98) | % | |||||||||||
| Interest expense, net | 60.4 | 58.8 | 3 | % | |||||||||||||
| Other income, net | 14.0 | (156.9) | >100% | ||||||||||||||
| Reported operating income | $ | 77.8 | $ | 43.5 | 79 | % | |||||||||||
| Reported operating income (loss) margin | 5.6 | % | 3.4 | % | |||||||||||||
| Amortization expense | 48.5 | 48.2 | 1 | % | |||||||||||||
| Restructuring and other business realignment costs | (1.7) | (1.3) | (31) | % | |||||||||||||
| Stock-based compensation | 20.5 | 33.6 | (39) | % | |||||||||||||
| Early license termination and market exit costs | (1.2) | (1.3) | 8 | % | |||||||||||||
| Total adjustments to reported operating income | $ | 66.1 | $ | 79.2 | (17) | % | |||||||||||
| Adjusted operating income | $ | 143.9 | $ | 122.7 | 17 | % | |||||||||||
| Adjusted operating income margin | 10.4 | % | 9.5 | % | |||||||||||||
| Adjusted depreciation | 56.0 | 59.2 | (5) | % | |||||||||||||
| Adjusted EBITDA | $ | 199.9 | $ | 181.9 | 10 | % | |||||||||||
| Adjusted EBITDA margin | 14.4 | % | 14.1 | % | |||||||||||||
In the three months ended March 31, 2024, adjusted operating income increased $21.2 to $143.9 from $122.7 in the three months ended March 31, 2023. Adjusted operating margin increased to 10.4% of net revenues in the three months ended March 31, 2024 from 9.5% in the three months ended March 31, 2023, primarily driven by a decrease in cost of goods sold as a percentage of net revenues and a decrease in stock-based compensation expense. In the three months ended March 31, 2024, adjusted EBITDA increased $18.0 to $199.9 from $181.9 in the three months ended March 31, 2023. Adjusted EBITDA margin increased to 14.4% of net revenues in the three months ended March 31, 2024 from 14.1% in the three months ended March 31, 2023.
45
Segment Operating Income (Loss), Segment Adjusted Operating Income (Loss) and Segment Adjusted EBITDA
Operating Income, Adjusted Operating Income and Adjusted EBITDA - Prestige Segment
| Three Months Ended March 31, | |||||||||||||||||
| (in millions) | 2024 | 2023 | Change % | ||||||||||||||
| Reported operating income | $ | 108.7 | $ | 102.4 | 6 | % | |||||||||||
| Reported operating income (loss) margin | 12.5 | % | 12.8 | % | |||||||||||||
| Amortization expense | 38.6 | 38.3 | 1 | % | |||||||||||||
| Total adjustments to reported operating income | $ | 38.6 | $ | 38.3 | 1 | % | |||||||||||
| Adjusted operating income | $ | 147.3 | $ | 140.7 | 5 | % | |||||||||||
| Adjusted operating income margin | 17.0 | % | 17.6 | % | |||||||||||||
| Adjusted depreciation | 25.7 | 28.6 | (10) | % | |||||||||||||
| Adjusted EBITDA | $ | 173.0 | $ | 169.3 | 2 | % | |||||||||||
| Adjusted EBITDA margin | 19.9 | % | 21.2 | % | |||||||||||||
Operating Loss, Adjusted Operating Loss and Adjusted EBITDA - Consumer Beauty Segment
| Three Months Ended March 31, | |||||||||||||||||
| (in millions) | 2024 | 2023 | Change % | ||||||||||||||
| Reported operating loss | $ | (13.3) | $ | (27.9) | 52 | % | |||||||||||
| Reported operating income (loss) margin | (2.6) | % | (5.7) | % | |||||||||||||
| Amortization expense | 9.9 | 9.9 | — | % | |||||||||||||
| Total adjustments to reported operating income | $ | 9.9 | $ | 9.9 | — | % | |||||||||||
| Adjusted operating loss | $ | (3.4) | $ | (18.0) | 81 | % | |||||||||||
| Adjusted operating income (loss) margin | (0.7) | % | (3.7) | % | |||||||||||||
| Adjusted depreciation | 30.3 | 30.6 | (1) | % | |||||||||||||
| Adjusted EBITDA | $ | 26.9 | $ | 12.6 | >100% | ||||||||||||
| Adjusted EBITDA margin | 5.2 | % | 2.6 | % | |||||||||||||
Operating Loss, Adjusted Operating Loss and Adjusted EBITDA - Corporate Segment
| Three Months Ended March 31, | |||||||||||||||||
| (in millions) | 2024 | 2023 | Change % | ||||||||||||||
| Reported operating loss | $ | (17.6) | $ | (31.0) | 43 | % | |||||||||||
| Reported operating income (loss) margin | N/A | N/A | |||||||||||||||
| Restructuring and other business realignment costs | (1.7) | (1.3) | (31) | % | |||||||||||||
| Stock-based compensation | 20.5 | 33.6 | (39) | % | |||||||||||||
| Early license termination and market exit costs | (1.2) | (1.3) | 8 | % | |||||||||||||
| Total adjustments to reported operating income | $ | 17.6 | $ | 31.0 | (43) | % | |||||||||||
| Adjusted operating income | $ | — | $ | — | N/A | ||||||||||||
| Adjusted operating income margin | N/A | N/A | |||||||||||||||
| Adjusted depreciation | — | — | N/A | ||||||||||||||
| Adjusted EBITDA | $ | — | $ | — | N/A | ||||||||||||
| Adjusted EBITDA margin | N/A | N/A | |||||||||||||||
46
Amortization Expense
In the three months ended March 31, 2024, amortization expense increased to $48.5 from $48.2 in the three months ended March 31, 2023. In the three months ended March 31, 2024, amortization expense of $38.6 and $9.9 was reported in the Prestige and Consumer Beauty segments, respectively. In the three months ended March 31, 2023, amortization expense of $38.3 and $9.9 was reported in the Prestige and Consumer Beauty segments, respectively.
Restructuring and Other Business Realignment Costs
We incurred $521.1 of cash costs life-to-date related to our previously announced and substantially completed Transformation Plan as of March 31, 2024, which have been recorded in Corporate. In addition, we continue to analyze our cost structure and evaluate opportunities to streamline operations through a range of other cost reduction activities ("Current Restructuring Actions").
In the three months ended March 31, 2024, we incurred a credit in restructuring and other business structure realignment costs of $(1.7), as follows:
•We incurred restructuring costs of $0.9 primarily related to the Current Restructuring Actions, included in the Condensed Consolidated Statements of Operations; and
•We incurred a credit in business structure realignment costs of $(2.6), which is reported in selling, general and administrative expenses.
In the three months ended March 31, 2023, we incurred a credit in restructuring and other business structure realignment costs of $(1.3) as follows:
•We incurred a credit in restructuring costs of $(1.3) primarily related to the Transformation Plan due to the change in estimate, included in the Condensed Consolidated Statements of Operations; and
•We incurred no business structure realignment costs.
Stock-Based Compensation
In the three months ended March 31, 2024, stock-based compensation was $20.5 as compared with $33.6 in the three months ended March 31, 2023. The decrease in stock-based compensation is primarily related to a reduction in expense recognized in connection with awards granted to the CEO.
Early License Termination and Market Exit Costs
In the three months ended March 31, 2024, we recognized a gain of $(1.2) related to our decision to wind down our business in Russia.
In the three months ended March 31, 2023, we recognized a gain of $(1.3) related to our decision to wind down our business in Russia.
Adjusted Depreciation Expense
In the three months ended March 31, 2024, adjusted depreciation expense of $25.7 and $30.3 was reported in the Prestige and Consumer Beauty segments, respectively. In the three months ended March 31, 2023, adjusted depreciation expense of $28.6 and $30.6 was reported in the Prestige and Consumer Beauty segments, respectively.
INTEREST EXPENSE, NET
In the three months ended March 31, 2024, net interest expense was $60.4 as compared with $58.8 in the three months ended March 31, 2023, remaining relatively flat compared to the prior period.
OTHER INCOME/EXPENSE
In the three months ended March 31, 2024, other expense was $14.0 as compared with other income of $156.9 in the three months ended March 31, 2023.
Other expense of $14.0 in the three months ended March 31, 2024 was principally comprised of net losses on forward repurchase contracts of $17.2.
Other income of $156.9 in the three months ended March 31, 2023 was principally comprised of net gains on forward repurchase contracts of $156.5.
The decrease in Other income of $170.9 is primarily due to net losses on forward repurchase contracts of $173.7 compared to the prior year period.
47
INCOME TAXES
The effective income tax rate for the three months ended March 31, 2024 and 2023 was (158.8)% and 21.0%, respectively. The effective tax rate of (158.8)% for the three months ended March 31, 2024, was primarily due to a benefit of $8.5 on the resolution of foreign uncertain tax positions compared to $3.4 of income in the period.
The effective tax rate of 21.0% in the three months ended March 31, 2023, was increased due to a large limitation on the deductibility of executive stock compensation offset by large fair value gains related to the investment in the Wella business taxed at a rate below the statutory tax rate of 21% as well as a foreign exchange loss recognized on repatriation of funds that were previously taxed.
The effective income tax rates vary from the U.S. federal statutory rate of 21% due to the effect of (i) jurisdictions with different statutory rates, including impacts of rate changes, (ii) adjustments to the Company’s unrealized tax benefits (“UTBs”) and accrued interest, (iii) non-deductible expenses, (iv) audit settlements and (v) valuation allowance changes. Our effective tax rate could fluctuate significantly and could be adversely affected to the extent earnings are lower than anticipated in countries that have lower statutory rates and higher than anticipated in countries that have higher statutory rates.
Reconciliation of Reported Income Before Income Taxes to Adjusted Income Before Income Taxes and Effective Tax Rates:
| Three Months Ended March 31, 2024 | Three Months Ended March 31, 2023 | ||||||||||||||||||||||||||||||||||||||||
| (in millions) | Income Before Income Taxes | Provision for Income Taxes | Effective Tax Rate | Income Before Income Taxes | Provision for Income Taxes | Effective Tax Rate | |||||||||||||||||||||||||||||||||||
| Reported income before income taxes | $ | 3.4 | $ | (5.4) | (158.8) | % | $ | 141.6 | $ | 29.8 | 21.0 | % | |||||||||||||||||||||||||||||
Adjustments to reported operating income (a) | 66.1 | 79.2 | |||||||||||||||||||||||||||||||||||||||
Change in fair value of investment in Wella Business (c) | (3.0) | — | |||||||||||||||||||||||||||||||||||||||
Other adjustments (d) | 0.2 | 0.2 | |||||||||||||||||||||||||||||||||||||||
Total Adjustments (b) | 63.3 | 18.3 | 79.4 | 14.8 | |||||||||||||||||||||||||||||||||||||
| Adjusted income before income taxes | $ | 66.7 | $ | 12.9 | 19.3 | % | $ | 221.0 | $ | 44.6 | 20.2 | % | |||||||||||||||||||||||||||||
(a)See a description of adjustments under “Net Income, Adjusted Operating Income and Adjusted EBITDA for Coty Inc.”
(b)The tax effects of each of the items included in adjusted income are calculated in a manner that results in a corresponding income tax expense/provision for adjusted income. In preparing the calculation, each adjustment to reported income is first analyzed to determine if the adjustment has an income tax consequence. The provision for taxes is then calculated based on the jurisdiction in which the adjusted items are incurred, multiplied by the respective statutory rates and offset by the increase or reversal of any valuation allowances commensurate with the non-GAAP measure of profitability.
(c)The amount represents the realized and unrealized (gain) loss recognized for the change in fair value of the investment in Wella.
(d)For the three months ended March 31, 2024 and 2023, this primarily represents loss from our equity investment in KKW.
The adjusted effective tax rate was 19.3% for the three months ended March 31, 2024 compared to 20.2% for the three months ended March 31, 2023. The differences were primarily due to the resolution of foreign uncertain tax positions having a greater proportional effect in the current period.
NET INCOME (LOSS) ATTRIBUTABLE TO COTY INC.
Net income attributable to Coty Inc. was $3.8 in the three months ended March 31, 2024 as compared to net income of $108.4 in the three months ended March 31, 2023. The decrease in the income was primarily driven by gains of $173.7 from forward repurchase contracts in the prior period that did not reoccur in the current period, partially offset by higher operating income of $34.3 in the current period.
We believe that adjusted net income attributable to Coty Inc. provides an enhanced understanding of our performance. See “Overview—Non-GAAP Financial Measures.”
48
| Three Months Ended March 31, | |||||||||||||||||
| (in millions) | 2024 | 2023 | Change % | ||||||||||||||
| Net income from Coty Inc. net of noncontrolling interests | $ | 3.8 | $ | 108.4 | (96) | % | |||||||||||
Convertible Series B Preferred Stock dividends (a) | (3.3) | (3.3) | — | % | |||||||||||||
| Reported net income attributable to Coty Inc. | $ | 0.5 | $ | 105.1 | (100) | % | |||||||||||
| % of net revenues | — | % | 8.2 | % | |||||||||||||
Adjustments to reported operating income (b) | 66.1 | 79.2 | (17) | % | |||||||||||||
Change in fair value of investment in Wella Company (c) | (3.0) | — | N/A | ||||||||||||||
Adjustment to other expense (d) | 0.2 | 0.2 | — | % | |||||||||||||
Adjustments to noncontrolling interests (e) | (1.7) | (1.6) | (6) | % | |||||||||||||
| Change in tax provision due to adjustments to reported net income attributable to Coty Inc. | (18.3) | (14.8) | (24) | % | |||||||||||||
| Adjusted net income attributable to Coty Inc. | $ | 43.8 | $ | 168.1 | (74) | % | |||||||||||
| % of net revenues | 3.2 | % | 13.0 | % | |||||||||||||
| Per Share Data | |||||||||||||||||
| Adjusted weighted-average common shares | |||||||||||||||||
| Basic | 883.1 | 851.6 | |||||||||||||||
Diluted (a) | 892.0 | 888.9 | |||||||||||||||
| Adjusted net income attributable to Coty Inc. per common share | |||||||||||||||||
| Basic | $ | 0.05 | $ | 0.20 | |||||||||||||
Diluted (a) | $ | 0.05 | $ | 0.19 | |||||||||||||
(a)Adjusted Diluted EPS is adjusted by the effect of dilutive securities. For the three months ended March 31, 2024 and 2023, shares for the Forward Repurchase Contracts were excluded from the computation of adjusted diluted EPS as Coty is in the position to receive shares from the counterparties and as such their inclusion would be anti-dilutive. Accordingly, we did not reverse the impact of the fair market value losses/(gains) for contracts with the option to settle in shares or cash of $7.1 and $(93.9), respectively. For the three months ended March 31, 2024, convertible Series B Preferred Stock (23.7 million weighted average dilutive shares) were anti-dilutive. Accordingly, we excluded these shares from the diluted shares and did not adjust the earnings for the related dividend of $3.3. For the three months ended March 31, 2023, as the Convertible Series B Preferred Stock was dilutive, an adjustment to reverse the impact of the preferred stock dividends of $3.3 was required.
(b)See a description of adjustments under “Adjusted Operating Income for Continuing Operations."
(c)For the three months ended March 31, 2024 and 2023, the amount represents the unrealized (gain) loss recognized for the change in fair value of the investment in Wella.
(d)For the three months ended March 31, 2024 and 2023, this primarily represents adjustments for equity loss from KKW.
(e)The amounts represent the after-tax impact of the non-GAAP adjustments included in net income attributable to noncontrolling interests based on the relevant noncontrolling interest percentage in the Condensed Consolidated Statements of Operations.
49
NINE MONTHS ENDED MARCH 31, 2024 AS COMPARED TO NINE MONTHS ENDED MARCH 31, 2023
NET REVENUES
In the nine months ended March 31, 2024, net revenues increased 13%, or $552.1, to $4,754.6 from $4,202.5 in the nine months ended March 31, 2023. Excluding net revenue from the first and second quarters of the prior period from Russia and the third quarter of the prior period from Lacoste, net revenues increased 15% or $615.1 to $4,754.6 from $4,139.5 in the nine months ended March 31, 2023, reflecting a positive price and mix impact of 11%, positive foreign currency exchange translation impact of 2%, and an increase in unit volume of 2%. The overall increase in net revenues reflects growth in our prestige fragrance category due to the continued success of fragrance brands, specifically Burberry, Hugo Boss, Calvin Klein, Gucci, Chloe, Marc Jacobs, Davidoff and Joop, as well as innovation from the launches including Marc Jacobs Daisy Wild and Cosmic Kylie Jenner, and positive performance in the prestige cosmetics category. The overall increase in net revenues for the Consumer Beauty segment was due to positive performance in the color cosmetics category specifically from Rimmel Manhattan and Risque, mass fragrance category specifically from David Beckham, and the skin and body care category in Brazil, specifically from Monange, Bozzano and Paixao.
The overall increase in net revenues reflects the continued success of our pricing and revenue management strategies, including the implementation of targeted price increases across our product portfolio earlier in the fiscal year. Volume growth across our fragrance portfolio, as well as in skin and body care products in Brazil helped drive the increase in revenues, partially offset by volume declines from certain color cosmetic and other body care brands in China due to macroeconomic conditions.
Geographically, except for China, net revenues in all major markets grew, led by Brazil, the United States, and Germany. Additionally, there was an increase in travel retail channel sales in all regions.
Digital and e-commerce channel sales growth also contributed to the increase in net revenues.
Net Revenues by Segment
| Nine Months Ended March 31, | |||||||||||||||||
| (in millions) | 2024 | 2023 | Change % | ||||||||||||||
| NET REVENUES | |||||||||||||||||
| Prestige | $ | 3,054.5 | $ | 2,620.9 | 17 | % | |||||||||||
| Consumer Beauty | 1,700.1 | 1,581.6 | 8 | % | |||||||||||||
| Total | $ | 4,754.6 | $ | 4,202.5 | 13 | % | |||||||||||
Prestige
In the nine months ended March 31, 2024, net revenues from the Prestige segment increased 17%, or $433.6, to $3,054.5 from $2,620.9 in the nine months ended March 31, 2023. Excluding net revenue from the first and second quarters of the prior period from Russia and the third quarter of the prior period from Lacoste, net revenues from the Prestige segment increased 19% or $477.9 to $3,054.5 from $2,576.6 in the nine months ended March 31, 2023, reflecting a positive price and mix impact of 10% (primarily due to the positive pricing impact as a result of global price increases earlier in the fiscal year, in line with the overall premiumization strategy and brand innovation), an increase in unit volume of 7%, and positive foreign currency exchange translation impact of 2%. The increase in net revenues primarily reflects:
•Prestige fragrance sales growth of $446.7, primarily due to the continued success of Burberry Goddess, Classic, Her and Hero, Hugo Boss Boss Bottled and Boss the Scent, Calvin Klein One, Euphoria, and Eternity, Gucci Guilty and Flora, Chloe Nomade and Signature, Marc Jacobs Daisy Wild, Davidoff Cool Water, and Joop Homme, as well as continued brand innovation such as Cosmic Kylie Jenner. Prestige fragrance sales grew in major markets such as the United States, Germany, and Australia, as well as through travel retail channel sales across all regions. This growth was partially offset by lower net revenues for the Lacoste brand in the first six months of the current period, which was primarily due to the early license termination resulting in a wind down of sales through the end of the second quarter; and lower net revenues for the Bottega Veneta brand in the current period, which was primarily due to the license expiration; and
•Prestige cosmetic sales growth of $21.4, primarily due to brand innovation from Kylie cosmetics and Gucci makeup.
50
Consumer Beauty
In the nine months ended March 31, 2024, net revenues from the Consumer Beauty segment increased 8%, or $118.5, to $1,700.1 from $1,581.6 in the nine months ended March 31, 2023. Excluding net revenue from the first and second quarters of the prior period from Russia, net revenues from the Consumer Beauty segment increased 9% or $137.2 to $1,700.1 from $1,562.9 in the nine months ended March 31, 2023, reflecting a positive price and mix impact of 5% (primarily due to price increases across the Consumer Beauty product portfolio earlier in the fiscal year), a positive foreign currency exchange translation impact of 2%, and an increase in unit volume of 2% (primarily due to Brazilian brands). The increase in net revenues primarily reflects:
•Color cosmetics sales growth of $53.5, primarily due to the continued success of Rimmel Manhattan which saw continued brand innovation, such as Lasting Finish foundation and Thrill Seeker mascara, and Risque due to strong category momentum in Brazil and positive pricing impact, despite a category slowdown in the US;
•Skin and body care sales growth of $43.4, due to the continued success of Brazilian brands Monange, Bozzano, and Paixao benefiting from strong category momentum and positive pricing impact. This growth was partially offset by lower sales volume for adidas primarily as a result of category slowdown in China;
•Mass fragrance sales growth of $37.3, due to the continued success from the re-launch of David Beckham Instinct in the current period.
COST OF SALES
In the nine months ended March 31, 2024, cost of sales increased 12%, or $186.1, to $1,690.8 from $1,504.7 in the nine months ended March 31, 2023. Cost of sales as a percentage of net revenues decreased to 35.6% in the nine months ended March 31, 2024 from 35.8% in the nine months ended March 31, 2023 resulting in a gross margin increase of approximately 20 basis points primarily reflecting:
(i)approximately 70 basis points related to a decrease in manufacturing and material costs as a percentage of net revenues, driven by increased manufacturing efficiencies, improvements in productivity, as well as procurement and material cost optimization; and
(ii)approximately 60 basis points related to decreased freight costs.
These increases were partially offset by:
(i)approximately 70 basis points related to an increase in excess and obsolescence costs primarily associated with the Prestige product portfolio; and
(ii)approximately 40 basis points related to an increase in designer license fees due to licensed Prestige brands comprising a larger portion of overall net revenues in the current period as well as favorable royalty activity in the prior period, which did not reoccur in the current period.
The above reflects a positive impact from pricing net of inflation of approximately 130 basis points.
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES
In the nine months ended March 31, 2024, selling, general and administrative expenses increased 11%, or $226.0, to $2,371.4 from $2,145.4 in the nine months ended March 31, 2023. Selling, general and administrative expenses as a percentage of net revenues decreased to 49.9% in the nine months ended March 31, 2024 from 51.1% in the nine months ended March 31, 2023, or approximately 120 basis points. This decrease was primarily due to:
(i)80 basis points due to a decrease in stock-based compensation cost primarily related to a reduction in expense recognized in connection with awards granted to the CEO;
(ii)40 basis points due to a decrease in logistics costs as a percentage of net revenues; and
(iii)40 basis points due to favorable transactional impact from our exposure to foreign currency as a percentage of net revenues; and
These decreases were partially offset by the following increases:
(i)40 basis points due to an increase in bad debt expense primarily related to a favorable activity in the prior period that did not reoccur in the current period.
51
OPERATING INCOME
In the nine months ended March 31, 2024, operating income was $512.0 compared to income of $414.7 in the nine months ended March 31, 2023. Operating margin as a percentage of net revenues, increased to 10.8% in the nine months ended March 31, 2024 as compared to an operating income as a percentage of net revenues of 9.9% in the nine months ended March 31, 2023. The increase in operating margin is largely driven by a decrease in stock compensation expense as a percentage of net revenues (approximately 80 basis points) primarily related to a reduction in expense recognized in connection with a prior year's grant made to the CEO, lower fixed costs as a percentage of net revenues (approximately 50 basis points) primarily related to non people-related costs, lower amortization expense as a percentage of net revenues (approximately 30 basis points), and lower cost of goods sold as a percentage of net revenues (approximately 20 basis points), partially offset by higher restructuring costs in the current period (approximately 90 basis points). In addition, the higher proportion of Consumer Beauty sales were from lower margin Brazil brands, compared to the prior year, negatively impacted our consolidated gross margin and operating income.
Operating Income (Loss) by Segment
| Nine Months Ended March 31, | |||||||||||||||||
| (in millions) | 2024 | 2023 | Change % | ||||||||||||||
| Operating income (loss) | |||||||||||||||||
| Prestige | $ | 531.0 | $ | 437.3 | 21 | % | |||||||||||
| Consumer Beauty | 79.0 | 53.3 | 48 | % | |||||||||||||
| Corporate | (98.0) | (75.9) | (29) | % | |||||||||||||
| Total | $ | 512.0 | $ | 414.7 | 23 | % | |||||||||||
Prestige
In the nine months ended March 31, 2024, operating income for Prestige was $531.0 compared to income of $437.3 in the nine months ended March 31, 2023. Operating margin increased to 17.4% of net revenues in the nine months ended March 31, 2024 as compared to 16.7% in the nine months ended March 31, 2023, driven primarily by a decrease in amortization expense as a percentage of net revenues (approximately 50 basis points) and a decrease in fixed costs as a percentage of net revenues (approximately 40 basis points) primarily related to non people-related costs.
Consumer Beauty
In the nine months ended March 31, 2024, operating income for Consumer Beauty was $79.0 compared to income of $53.3 in the nine months ended March 31, 2023. Operating margin increased to 4.6% of net revenues in the nine months ended March 31, 2024 as compared to 3.4% in the nine months ended March 31, 2023, driven by a decrease in transactional foreign exchange losses as a percentage of net revenues (approximately 50 basis points) primarily related to currency revaluation in Argentina in the prior year, a decrease in advertising and consumer promotional expense as a percentage of net revenues (approximately 50 basis points) primarily due to a decrease in working media, and a decrease in fixed costs as a percentage of net revenues (approximately 20 basis points) primarily related to non-people related costs.
Corporate
Corporate primarily includes corporate expenses not directly related to our operating activities. These items are included in Corporate since we consider them to be Corporate responsibilities, and these items are not used by our management to measure the underlying performance of the segments.
In the nine months ended March 31, 2024, the operating loss for Corporate was $98.0 compared to a loss of $75.9 in the nine months ended March 31, 2023, as described under “Adjusted Operating Income for Coty Inc.” below. The increase to the operating loss for Corporate was primarily driven by an increase of $40.4 in restructuring costs in the current period, partially offset by a decrease of $27.0 in stock compensation expense in the current period.
52
Adjusted Operating Income by Segment
We believe that Adjusted Operating income by segment further enhances an investor’s understanding of our performance. See “Overview—Non-GAAP Financial Measures.” A reconciliation of reported Operating income to Adjusted Operating income is presented below, by segment:
| Nine Months Ended March 31, 2024 | |||||||||||||||||
| (in millions) | Reported (GAAP) | Adjustments (a) | Adjusted (Non-GAAP) | ||||||||||||||
| Operating income | |||||||||||||||||
| Prestige | 531.0 | $ | 115.6 | $ | 646.6 | ||||||||||||
| Consumer Beauty | 79.0 | 29.8 | 108.8 | ||||||||||||||
| Corporate | (98.0) | 98.0 | — | ||||||||||||||
| Total | $ | 512.0 | $ | 243.4 | $ | 755.4 | |||||||||||
| Nine Months Ended March 31, 2023 | |||||||||||||||||
| (in millions) | Reported (GAAP) | Adjustments (a) | Adjusted (Non-GAAP) | ||||||||||||||
| Operating income | |||||||||||||||||
| Prestige | 437.3 | $ | 112.7 | $ | 550.0 | ||||||||||||
| Consumer Beauty | 53.3 | 30.4 | 83.7 | ||||||||||||||
| Corporate | (75.9) | 75.9 | — | ||||||||||||||
| Total | $ | 414.7 | $ | 219.0 | $ | 633.7 | |||||||||||
(a)See a reconciliation of reported net income to operating income (loss) to adjusted operating income (loss) and adjusted EBITDA for Coty Inc. and reconciliations of segment operating income (loss) to segment adjusted operating income (loss) and segment adjusted EBITDA for the Prestige, Consumer Beauty and Corporate segments with a description of the adjustments under “Net Income, Adjusted Operating Income and Adjusted EBITDA for Coty Inc.” and “Segment Operating Income (Loss), Segment Adjusted Operating Income (Loss) and Segment Adjusted EBITDA”, below. All adjustments are reflected in Corporate, except for amortization and asset impairment charges on goodwill, indefinite-lived intangible assets, and finite-lived intangible assets, which are reflected in the Prestige and Consumer Beauty segments.
53
Net Income, Adjusted Operating Income and Adjusted EBITDA for Coty Inc.
We believe that adjusted operating income further enhances an investor’s understanding of our performance. See “Overview—Non-GAAP Financial Measures.” A reconciliation of reported operating income to adjusted operating income is presented below:
| Nine Months Ended March 31, | |||||||||||||||||
| (in millions) | 2024 | 2023 | Change % | ||||||||||||||
| Net income (loss) | $ | 205.0 | $ | 487.7 | (58) | % | |||||||||||
| Net income margin | 4.3 | % | 11.6 | % | |||||||||||||
| Provision (benefit) for income taxes | 106.9 | 138.3 | (23) | % | |||||||||||||
| Income (loss) before income taxes | $ | 311.9 | $ | 626.0 | (50) | % | |||||||||||
| Interest expense, net | 190.3 | 185.7 | 2 | % | |||||||||||||
| Other income, net | 9.8 | (397.0) | >100% | ||||||||||||||
| Reported operating income | $ | 512.0 | $ | 414.7 | 23 | % | |||||||||||
| Reported operating income (loss) margin | 10.8 | % | 9.9 | % | |||||||||||||
| Amortization expense | 145.4 | 143.1 | 2 | % | |||||||||||||
| Restructuring and other business realignment costs | 29.6 | (5.0) | >100% | ||||||||||||||
| Stock-based compensation | 70.4 | 98.9 | (29) | % | |||||||||||||
| Gain on sale of real estate | (1.6) | (1.0) | (60) | % | |||||||||||||
| Early license termination and market exit costs | (0.4) | (17.0) | 98 | % | |||||||||||||
| Total adjustments to reported operating income | $ | 243.4 | $ | 219.0 | 11 | % | |||||||||||
| Adjusted operating income | $ | 755.4 | $ | 633.7 | 19 | % | |||||||||||
| Adjusted operating income margin | 15.9 | % | 15.1 | % | |||||||||||||
| Adjusted depreciation | 171.2 | 173.7 | (1) | % | |||||||||||||
| Adjusted EBITDA | $ | 926.6 | $ | 807.4 | 15 | % | |||||||||||
| Adjusted EBITDA margin | 19.5 | % | 19.2 | % | |||||||||||||
In the nine months ended March 31, 2024, adjusted operating income increased $121.7, to $755.4 from $633.7 in the nine months ended March 31, 2023. Adjusted operating margin increased to 15.9% of net revenues in the nine months ended March 31, 2024 from 15.1% in the nine months ended March 31, 2023, primarily due to a decrease in stock compensation expense as a percentage of net revenues, a decrease in fixed costs as a percentage of net revenues, a decrease in amortization expense as a percentage of net revenues and a decrease in costs of goods sold as a percentage of net revenues, partially offset by an increase in restructuring costs as a percentage of net revenues. In the nine months ended March 31, 2024, adjusted EBITDA increased $119.2 to $926.6 from $807.4 in the nine months ended March 31, 2023. Adjusted EBITDA margin increased to 19.5% of net revenues in the nine months ended March 31, 2024 from 19.2% in the nine months ended March 31, 2023.
54
Segment Operating Income (Loss), Segment Adjusted Operating Income (Loss) and Segment Adjusted EBITDA
Operating Income, Adjusted Operating Income and Adjusted EBITDA - Prestige Segment
| Nine Months Ended March 31, | |||||||||||||||||
| (in millions) | 2024 | 2023 | Change % | ||||||||||||||
| Reported operating income | 531.0 | 437.3 | 21 | % | |||||||||||||
| Reported operating income (loss) margin | 17.4 | % | 16.7 | % | |||||||||||||
| Amortization expense | 115.6 | 112.7 | 3 | % | |||||||||||||
| Total adjustments to reported operating income | $ | 115.6 | $ | 112.7 | 3 | % | |||||||||||
| Adjusted operating income | $ | 646.6 | $ | 550.0 | 18 | % | |||||||||||
| Adjusted operating income margin | 21.2 | % | 21.0 | % | |||||||||||||
| Adjusted depreciation | 80.2 | 82.9 | (3) | % | |||||||||||||
| Adjusted EBITDA | $ | 726.8 | $ | 632.9 | 15 | % | |||||||||||
| Adjusted EBITDA margin | 23.8 | % | 24.1 | % | |||||||||||||
Operating Income, Adjusted Operating Income and Adjusted EBITDA - Consumer Beauty Segment
| Nine Months Ended March 31, | |||||||||||||||||
| (in millions) | 2024 | 2023 | Change % | ||||||||||||||
| Reported operating income | 79.0 | 53.3 | 48 | % | |||||||||||||
| Reported operating income (loss) margin | 4.6 | % | 3.4 | % | |||||||||||||
| Amortization expense | 29.8 | 30.4 | (2) | % | |||||||||||||
| Total adjustments to reported operating income | $ | 29.8 | $ | 30.4 | (2) | % | |||||||||||
| Adjusted operating income | $ | 108.8 | $ | 83.7 | 30 | % | |||||||||||
| Adjusted operating income margin | 6.4 | % | 5.3 | % | |||||||||||||
| Adjusted depreciation | 91.0 | 90.8 | — | % | |||||||||||||
| Adjusted EBITDA | $ | 199.8 | $ | 174.5 | 14 | % | |||||||||||
| Adjusted EBITDA margin | 11.8 | % | 11.0 | % | |||||||||||||
Operating Loss, Adjusted Operating Loss and Adjusted EBITDA - Corporate Segment
| Nine Months Ended March 31, | |||||||||||||||||
| (in millions) | 2024 | 2023 | Change % | ||||||||||||||
| Reported operating loss | $ | (98.0) | $ | (75.9) | (29) | % | |||||||||||
| Reported operating income (loss) margin | N/A | N/A | |||||||||||||||
| Restructuring and other business realignment costs | 29.6 | (5.0) | >100% | ||||||||||||||
| Stock-based compensation | 70.4 | 98.9 | (29) | % | |||||||||||||
| Gain on sale of real estate | (1.6) | (1.0) | (60) | % | |||||||||||||
| Early license termination and market exit costs | (0.4) | (17.0) | 98 | % | |||||||||||||
| Total adjustments to reported operating income | $ | 98.0 | $ | 75.9 | 29 | % | |||||||||||
| Adjusted operating income | $ | — | $ | — | N/A | ||||||||||||
| Adjusted operating income margin | N/A | N/A | |||||||||||||||
| Adjusted depreciation | — | — | N/A | ||||||||||||||
| Adjusted EBITDA | $ | — | $ | — | N/A | ||||||||||||
| Adjusted EBITDA margin | N/A | N/A | |||||||||||||||
Amortization Expense
In the nine months ended March 31, 2024, amortization expense increased to $145.4 from $143.1 in the nine months ended March 31, 2023. In the nine months ended March 31, 2024, amortization expense of $115.6 and $29.8 was reported in the Prestige and Consumer Beauty segments, respectively. In the nine months ended March 31, 2023, amortization expense of $112.7 and $30.4 was reported in the Prestige and Consumer Beauty segments, respectively.
55
Restructuring and Other Business Realignment Costs
We incurred $521.1 of cash costs life-to-date related to our previously announced and substantially completed Transformation Plan as of March 31, 2024, which have been recorded in Corporate. In addition, we continue to analyze our cost structure and evaluate opportunities to streamline operations through a range of other cost reduction activities ("Current Restructuring Actions").
In the nine months ended March 31, 2024, we incurred restructuring and other business structure realignment costs of $29.6, as follows:
•We incurred restructuring costs of $35.0 primarily related to the Current Restructuring Actions, included in the Condensed Consolidated Statements of Operations; and
•We incurred a credit in business structure realignment costs of $(5.4) which is reported in selling, general and administrative expenses.
In the nine months ended March 31, 2023, we incurred a credit in restructuring and other business structure realignment costs of $(5.0) as follows:
•We incurred a credit in restructuring costs of $(5.4) primarily related to the Transformation Plan, included in the Condensed Consolidated Statements of Operations.
•We incurred business structure realignment costs of $0.4 primarily related to our Transformation Plan and certain other programs. This amount includes $0.9 reported in Cost of sales in the Condensed Consolidated Statement of Operations and a credit of $(0.5) reported in Selling, general and administrative expenses.
Stock-based compensation
In the nine months ended March 31, 2024, stock-based compensation was $70.4 as compared with $98.9 in the nine months ended March 31, 2023. The decrease in stock-based compensation is primarily related to a reduction in expense recognized in connection with awards granted to the CEO.
Gain on Sale of Real Estate
In the nine months ended March 31, 2024 and 2023 we recognized gain of $(1.6) and $(1.0), respectively, related to sale of real estate.
Early License Termination and Market Exit Costs
In the nine months ended March 31, 2024, we recognized a gain of $(0.4) related to the early termination of a license and our decision to wind down our business in Russia.
In the nine months ended March 31, 2023, we recognized a gain of $(17.0) related to our decision to wind down our business in Russia.
Adjusted Depreciation Expense
In the nine months ended March 31, 2024, adjusted depreciation expense of $80.2 and $91.0 was reported in the Prestige and Consumer Beauty segments, respectively. In the nine months ended March 31, 2023, adjusted depreciation expense of $82.9 and $90.8 was reported in the Prestige and Consumer Beauty segments, respectively.
INTEREST EXPENSE, NET
In the nine months ended March 31, 2024, net interest expense was $190.3 as compared with $185.7 in the nine months ended March 31, 2023. This increase is primarily due to higher foreign exchange losses, net of derivative contracts, the impact of a higher average interest rate despite lower debt balances in the current period, and lower amortization expense of deferred financing fees in the current period.
OTHER INCOME/EXPENSE
In the nine months ended March 31, 2024, other expense was $9.8 as compared to other income of $397.0 in the nine months ended March 31, 2023.
Other expense of $9.8 in the nine months ended March 31, 2024 was principally comprised of net losses on forward repurchase contracts of $20.8 and deferred financing fees of $7.4, partially offset by fair value gains related to our equity investment in Wella of $20.0, and gains associated with earn-out provisions related to our sale of Wella of $9.9.
Other income of $397.0 in the nine months ended March 31, 2023 was principally comprised of gains related to our equity investment in the Wella company of $210.0, net gains on forward repurchase contracts of $167.1, and gains associated with earn-out provisions related to our sale of Wella of $28.5.
56
This decrease in Other income of $406.8 is primarily due to a less favorable fair value adjustment of $190.0 related to our equity investment in the Wella Company compared to the prior period, net losses on forward repurchase contracts of $187.9 compared to the prior year period, lower gains of $18.6 associated with earn-out provisions related to our sale of Wella as compared to the prior period.
INCOME TAXES
The effective income tax rate for the nine months ended March 31, 2024 and 2023 was 34.3% and 22.1%, respectively. The effective tax rate of 34.3% for the nine months ended March 31, 2024, was driven up from the statutory tax rate of 21% due to an expense of $24.3 recognized in the current period on the revaluation of the Company's deferred tax liabilities due to a tax rate increase enacted in Switzerland, as well as the limitation on the deductibility of executive stock compensation.
The effective tax rate of 22.1% for the nine months ended March 31, 2023 was increased from the statutory tax rate of 21% due to a large limitation on the deductibility of executive stock compensation. The increase was then offset by large fair value gains related to the investment in the Wella business taxed at a rate below the statutory tax rate of 21% as well as a foreign exchange loss recognized on the repatriation of funds that were previously taxed.
The effective income tax rates vary from the U.S. federal statutory rate of 21% due to the effect of: (i) jurisdictions with different statutory rates, including impacts of rate changes, (ii) adjustments to our unrecognized tax benefits and accrued interest; (iii) non-deductible expenses, (iv) audit settlements and (v) valuation allowance changes. Our effective tax rate could fluctuate significantly and could be adversely affected to the extent earnings are lower than anticipated in countries that have lower statutory rates and higher than anticipated in countries that have higher statutory rates.
Reconciliation of Reported Income Before Income Taxes to Adjusted Income Before Income Taxes and Effective Tax Rates:
| Nine Months Ended March 31, 2024 | Nine Months Ended March 31, 2023 | ||||||||||||||||||||||||||||||||||
| (in millions) | Income Before Income Taxes | Provision for Income Taxes | Effective Tax Rate | Income Before Income Taxes | Provision for Income Taxes | Effective Tax Rate | |||||||||||||||||||||||||||||
| Reported income before income taxes | $ | 311.9 | $ | 106.9 | 34.3 | % | $ | 626.0 | $ | 138.3 | 22.1 | % | |||||||||||||||||||||||
Other adjustments to reported operating income (a) | 243.4 | 219.0 | |||||||||||||||||||||||||||||||||
Change in fair value of investment in Wella Business (c) | (20.0) | (210.0) | |||||||||||||||||||||||||||||||||
Other adjustments (d) | 4.3 | 0.6 | |||||||||||||||||||||||||||||||||
Total Adjustments (b) | 227.7 | 52.0 | 9.6 | 17.2 | |||||||||||||||||||||||||||||||
| Adjusted income before income taxes | $ | 539.6 | $ | 158.9 | 29.4 | % | $ | 635.6 | $ | 155.5 | 24.5 | % | |||||||||||||||||||||||
(a)See a description of adjustments under “Net Income, Adjusted Operating Income and Adjusted EBITDA for Coty Inc.”
(b)The tax effects of each of the items included in adjusted income are calculated in a manner that results in a corresponding income tax expense/provision for adjusted income. In preparing the calculation, each adjustment to reported income is first analyzed to determine if the adjustment has an income tax consequence. The provision for taxes is then calculated based on the jurisdiction in which the adjusted items are incurred, multiplied by the respective statutory rates and offset by the increase or reversal of any valuation allowances commensurate with the non-GAAP measure of profitability.
(c)The amount represents the realized and unrealized (gain) loss recognized for the change in fair value of the investment in Wella.
(d)For the nine months ended March 31, 2024, this primarily this primarily represents divestiture-related costs related to our equity investments and loss from our equity investment in KKW. For the nine months ended March 31, 2023, this primarily represents adjustments for equity loss from KKW.
The adjusted effective tax rate was 29.4% for the nine months ended March 31, 2024 compared to 24.5% for the nine months ended March 31, 2023. The differences were primarily due to an expense of $24.3 in the current period recognized on the revaluation of the Company's deferred tax liabilities due to a tax rate increase enacted in Switzerland.
57
NET INCOME ATTRIBUTABLE TO COTY INC.
Net income attributable to Coty Inc. was $186.3 in the nine months ended March 31, 2024, as compared to net income of $475.3 in the nine months ended March 31, 2023. This decrease in net income was primarily driven by a less favorable fair value adjustment of $190.0 related to our investment in the Wella Company and net losses on forward repurchase contracts of $187.9 compared to the prior year period.
We believe that adjusted net income attributable to Coty Inc. provides an enhanced understanding of our performance. See “Overview—Non-GAAP Financial Measures.”
| Nine Months Ended March 31, | |||||||||||||||||
| (in millions) | 2024 | 2023 | Change % | ||||||||||||||
| Net income from Coty Inc. net of noncontrolling interests | 186.3 | 475.3 | (61) | % | |||||||||||||
Convertible Series B Preferred Stock dividends (a) | (9.9) | (9.9) | — | % | |||||||||||||
| Reported net income attributable to Coty Inc. | 176.4 | 465.4 | (62) | % | |||||||||||||
| % of net revenues | 3.7 | % | 11.1 | % | |||||||||||||
Adjustments to reported operating income (b) | 243.4 | 219.0 | 11 | % | |||||||||||||
Change in fair value of investment in Wella Company (c) | (20.0) | (210.0) | 90 | % | |||||||||||||
Adjustment to other expense (d) | 4.3 | 0.6 | >100% | ||||||||||||||
Adjustments to noncontrolling interests (e) | (5.1) | (5.1) | — | % | |||||||||||||
| Change in tax provision due to adjustments to reported net income attributable to Coty Inc. | (52.0) | (17.2) | <(100%) | ||||||||||||||
| Adjusted net income attributable to Coty Inc. | 347.0 | 452.7 | (23) | % | |||||||||||||
| % of net revenues | 7.3 | % | 10.8 | % | |||||||||||||
| Per Share Data | |||||||||||||||||
| Adjusted weighted-average common shares | |||||||||||||||||
| Basic | 876.7 | 848.1 | |||||||||||||||
Diluted (a) | 886.1 | 885.8 | |||||||||||||||
| Adjusted net income attributable to Coty Inc. per common share | |||||||||||||||||
| Basic | $ | 0.40 | $ | 0.54 | |||||||||||||
Diluted (a) | $ | 0.39 | $ | 0.52 | |||||||||||||
(a)Adjusted Diluted EPS is adjusted by the effect of dilutive securities. For the nine months ended March 31, 2024 and 2023, shares for the Forward Repurchase Contracts were excluded from the computation of adjusted diluted EPS as Coty is in the position to receive shares from the counterparties and as such their inclusion would be anti-dilutive. Accordingly, we did not reverse the impact of the fair market value losses/(gains) for contracts with the option to settle in shares or cash of $6.9 and $(100.7), respectively. For the nine months ended March 31, 2024, convertible Series B Preferred Stock (23.7 million weighted average dilutive shares) were anti-dilutive. Accordingly, we excluded these shares from the diluted shares and did not adjust the earnings for the related dividend of $9.9. For the nine months ended March 31, 2023, as the Convertible Series B Preferred Stock was dilutive, an adjustment to reverse the impact of the preferred stock dividends of $9.9 was required.
(b)See a description of adjustments under “Adjusted Operating Income for Continuing Operations”
(c)The amount represents the realized and unrealized (gain) loss recognized for the change in fair value of the investment in Wella.
(d)For the nine months ended March 31, 2024, this primarily divestiture-related costs related to our equity investments and loss from our equity investment in KKW. For the nine months ended March 31, 2023, this primarily represents loss from equity investment in KKW.
(e)The amounts represent the after-tax impact of the non-GAAP adjustments included in Net income (loss) attributable to noncontrolling interests based on the relevant noncontrolling interest percentage in the Condensed Consolidated Statements of Operations.
58
FINANCIAL CONDITION
LIQUIDITY AND CAPITAL RESOURCES
Overview
Our primary sources of funds include cash expected to be generated from operations, borrowings from issuance of debt and lines of credit provided by banks and lenders in the U.S. and abroad.
Our cash flows are subject to seasonal variation throughout the year, including demands on cash made during our first fiscal quarter in anticipation of higher global sales during the second fiscal quarter and strong cash generation in the second fiscal quarter as a result of increased demand by retailers associated with the holiday season.
Our principal uses of cash are to fund planned operating expenditures, capital expenditures, interest payments, dividends, share repurchases, any principal payments on debt, and from time to time, acquisitions, and business structure realignment expenditures. Working capital movements are influenced by the sourcing of materials related to the production of products. Cash and working capital management initiatives, including the phasing of vendor and tax payments and factoring of trade receivables from time-to-time, may also impact the timing and amount of our operating cash flows.
We remain focused on deleveraging our balance sheet using cash flows generated from our operations and other targeted initiatives. We continue to take steps to permanently reduce our debt to reduce interest costs and improve our long-term profitability and cash flows. Our 25.84% investment in Wella continues to give us the opportunity for further permanent debt reductions when our equity position is divested.
We have substantially completed the exit of our commercial activities in Russia. However, we anticipate that the process related to the liquidation of the Russian legal entity will take an extended period of time. We anticipate that we will incur an future net cash costs of $10.0 to $15.0, which will be funded by our Russian subsidiary. The amount of future costs, including cash costs, will be subject to various factors, such as additional government regulation and the resolution of legal contingencies.
The impact of inflation on material, logistical and other costs subsided during the nine months ended March 31, 2024, which was primarily driven by a significant easing during the second and third quarters. Inflation may continue to impact certain costs, such as labor, however, we currently anticipate the overall impact of inflation to continue to ease in the fourth quarter of fiscal 2024. Additionally, we continued to see improved order fill rates and achieved near pre-COVID-19 service levels beginning in the second quarter and anticipate being able to maintain this level of service into the foreseeable future.
Debt Financing
We are in the process of deleveraging our company and improving the maturity mix of our debt, including through refinancing or repayment of a portion of our debt.
We have taken action to reduce variability in our interest payments including paying down variable interest rate debt outstanding under our 2018 Coty Term B Facility and issuing fixed rate bonds. As a result, all of our long-term debt was fixed rate debt as of December 31, 2023 and our remaining floating-to-fixed interest rate swaps have been terminated.
In the first quarter of fiscal 2024, we amended the 2018 Coty Credit Agreement and replaced our existing revolving commitments with two tranches of revolving commitments, having an aggregate principal amount of $1,670.0 available in U.S. dollars and certain other currencies and the other in an aggregate principal amount of €300.0 million available in euros, and issued $750.0 and €500.0 million of senior secured notes due July 2030 and September 2028, respectively. The net proceeds received from the offerings were used to primarily pay down the outstanding balance of the U.S. dollar and euro portions of the 2018 Coty Term B Facility by $715.5 and €22.6 million (approximately $25.1), respectively and a portion of the borrowings outstanding under our revolving credit facility. In August 2023, we repaid the €408.0 million (approximately $446.1) of the debt outstanding under the 2018 Term B Facility, thus repaying the facility in full.
In the second quarter of fiscal 2024, one of our wholly-owned subsidiaries utilized cash on hand to fully pay down the U.S. Dollar-denominated credit facility in Brazil in the amount of $31.9. Additionally, we completed cash tender offers on December 7, 2023, and redeemed $150.0 of the Company’s 2026 Dollar Notes and $250.0 of the Company’s 2026 Dollar Senior Secured Notes. See Note 9—Debt in the notes to our Condensed Consolidated Financial Statements for additional information on our debt arrangements and prior period credit agreements, as well as definitions of capitalized terms.
We expect to continue to take actions to improve the maturity mix of our debt from time to time as market conditions permit.
59
Equity Offering
On September 28, 2023, we entered into an agreement with a group of underwriters to issue and sell 33.0 million shares of our Class A common stock, par value $0.01 per share (see Note 13—Equity and Convertible Preferred Stock for additional information). We used proceeds of approximately $348.4, net of underwriting fees, from this offering primarily to retire the principal amount of outstanding debt. Other uses included general corporate purposes, such as strategic investments in the business, working capital and capital expenditures. Settlement of the Offering occurred on October 2, 2023.
Share Repurchases
In connection with our Share Repurchase Program, we entered into forward repurchase contracts in June 2022, December 2022, and November 2023 with three large financial institutions to hedge for $200.0, and a potential $196.0 and $294.0 of share repurchases in 2024, 2025 and 2026, respectively.
We physically settled the June 2022 forward repurchase contracts by delivering approximately $200.0 cash in exchange for 27.0 million shares of our Class A Common Stock during the third quarter of fiscal 2024. The forward repurchase contracts permit a net cash settlement alternative in addition to the physical settlement. We may elect net cash settlement of all, or some of the remaining forward repurchase contracts based on factors such as timing, the market value of the underlying shares at the settlement date and other internal cash management considerations. We will continue to incur costs associated with the remaining forward repurchase contracts before settlement. Cash costs incurred in the current fiscal year to date for all forward repurchase contracts amounted to $34.0.
Factoring of Receivables
From time to time, we supplement the timing of our cash flows through the factoring of trade receivables. In this regard, we have entered into factoring arrangements with financial institutions.
The net amount utilized under the factoring facilities was $192.7 and $202.9 as of March 31, 2024 and June 30, 2023, respectively. The aggregate amount of trade receivable invoices factored on a worldwide basis amounted to $1,196.9 and $1,192.4 during the nine months ended March 31, 2024 and 2023, respectively.
Other Developments
We ended a previously existing distribution arrangement with Wella related to transition services for Wella Brazil in the third quarter of fiscal 2024, resulting in a net positive cash impact of approximately $35.0 during the nine months ended March 31, 2024 related to reimbursements for working capital financed by Coty since the separation of the Wella business.
Cash Flows
| Nine Months Ended March 31, | |||||||||||
| 2024 | 2023 | ||||||||||
| Condensed Consolidated Statements of Cash Flows Data: (in millions) | |||||||||||
| Net cash provided by operating activities | $ | 438.1 | $ | 520.8 | |||||||
| Net cash used in investing activities | (161.5) | (97.7) | |||||||||
| Net cash used in financing activities | (264.1) | (397.6) | |||||||||
Net cash provided by operating activities
Net cash provided by operating activities was $438.1 and $520.8 for the nine months ended March 31, 2024 and 2023, respectively. The decrease in cash provided by operating activities of $82.7 was primarily driven by a negative impact from accounts payable due to the timing of payments and vendor mix, as well higher cash outflows for tax payments. However, these decreases to cash flows from operating activities were partially offset by higher net inflows from all other net working capital accounts, including changes in inventory offset by changes in trade receivables. Changes in inventory year over year reflect the impact of prior year increases in safety stock focused on mitigating supply chain constraints compared to an inflow from inventory in the current year as the Company adjusted inventory levels to a more normal level. The outflow from accounts receivable was due to increases in net revenue and a slowdown in collections, partially offset by lower factoring. Additionally, offsetting activity was due to lower year over year payments for restructuring and a net inflow of $35.0 as a reimbursement from Wella for working capital financed by Coty since the separation of the Wella business.
60
Net cash used in investing activities
Net cash used in investing activities was $161.5 and $97.7 for the nine months ended March 31, 2024 and 2023, respectively. The increase in cash used in investing activities of $63.8 was primarily due to lower current year proceeds related to an early license termination, and the impact of timing and increased capital expenditures. The collection of contingent consideration and proceeds from the sale of other long-term assets in the current year helped to partially offset the year over year increase in cash used in investing activities.
Net cash used in financing activities
Net cash used in financing activities during the nine months ended March 31, 2024 and 2023 was $264.1 and $397.6, respectively. The decrease in cash used in financing activities of $133.5 was primarily driven by the net proceeds from the issuance of Class A Common Stock mainly in connection with the global offering and lower cash payments in the current year compared to the prior year from realized net losses on the Company’s financing related foreign currency contracts. The decrease in cash used for financing activities was partially offset by higher outflows in the current year related to the Company’s forward repurchase contracts which includes a cash payment for the settlement of the June 2022 forward repurchase contract, higher year over year net cash repayments from the Company’s debt related activities, as well as cash payments for associated deferred financing fees.
Dividends
On April 29, 2020, the Board of Directors suspended the payment of dividends on Common Stock. As previously disclosed, we expect to suspend the payment of dividends until we approach a Net debt to Adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”) target of 2x. We expect to consider any future resumption of dividends in line with that target while continuing to pursue our deleveraging agenda and implementing our strategic initiatives. Any determination to pay dividends in the future will be at the discretion of our Board of Directors.
Dividends on the Convertible Series B Preferred Stock are payable in cash, or by increasing the amount of accrued dividends on Convertible Series B Preferred Stock, or any combination thereof, at the sole discretion of the Company. We expect to pay such dividends in cash on a quarterly basis, subject to the declaration thereof by our Board of Directors. The terms of the Convertible Series B Preferred Stock restrict our ability to declare cash dividends on our common stock until all accrued dividends on the Convertible Series B Preferred Stock have been declared and paid in cash.
For additional information on our dividends, see Note 13—Equity and Convertible Preferred Stock in the notes to our Condensed Consolidated Financial Statements.
Treasury Stock - Share Repurchase Program
For information on our Share Repurchase Program, see Note 13—Equity and Convertible Preferred Stock in the notes to our Condensed Consolidated Financial Statements.
Commitments and Contingencies
See Note 16—Redeemable Noncontrolling Interests in the notes to our Condensed Consolidated Financial Statements for information on our subsidiary in the Middle East.
Legal Contingencies
For information on our litigation matters and Brazilian tax assessments, see Note 17—Commitments and Contingencies in the notes to our Condensed Consolidated Financial Statements. In relation to the appeal of our Brazilian tax assessments, we have entered into surety bonds of R$464.3 million (approximately $92.6) as of March 31, 2024.
Off-Balance Sheet Arrangements
We had undrawn letters of credit of $4.1 and $7.2 and bank guarantees of $21.1 and $16.3 as of March 31, 2024 and June 30, 2023, respectively.
61
Contractual Obligations
Our principal contractual obligations and commitments as of June 30, 2023 are summarized in Item 7 - “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources - Contractual Obligations and Commitments,” of our Fiscal 2023 Form 10-K. Refer to Item 2 - “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources - Share Repurchases” above for discussion of the obligations related to our announced share repurchase during fiscal 2024. For the nine months ended March 31, 2024, there have been no other material changes in our contractual obligations outside the ordinary course of business.
Critical Accounting Policies
We believe that the critical accounting policies listed below involve our more significant judgments, assumptions and estimates and, therefore, could have the greatest potential impact on our Condensed Consolidated Financial Statements:
•Revenue Recognition;
•Equity Investments;
•Goodwill, Other Intangible Assets and Long-Lived Assets;
•Inventory; and
•Income Taxes.
As of March 31, 2024, there have been no material changes to the items disclosed as critical accounting policies and estimates in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II—Item 7 of our Fiscal 2023 Form 10-K.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
See Note 12—Derivative Instruments for updates to our foreign currency risk management and interest rate risk management. There have been no material changes in market risk from the information provided in Item 7A. Quantitative and Qualitative Disclosures About Market Risk of our Fiscal 2023 Form 10-K.
Item 4. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
We maintain “disclosure controls and procedures,” as defined in Rules 13a-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to our management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.
Our management, with the participation of our Chief Executive Officer (the “CEO”) and our Chief Financial Officer (“CFO”), evaluated the effectiveness of our disclosure controls and procedures as of March 31, 2024. Based on the evaluation of our disclosure controls and procedures as of March 31, 2024, our CEO and CFO concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting identified in management’s evaluation pursuant to Rules 13a-15(f) of the Exchange Act during the third fiscal quarter that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Inherent Limitations on Effectiveness of Controls
Our management, including our CEO and CFO, believes that our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving our objectives and are effective at the reasonable assurance level. However, our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of a simple error
62
or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.
Part II. OTHER INFORMATION
Item 1. Legal Proceedings.
For information on our legal matters, see Note 17—Commitments and Contingencies in the notes to our Condensed Consolidated Financial Statements.
Item 1A. Risk Factors.
We have disclosed information about the risk factors that could adversely affect our business in Part I, Item 1A under the heading “Risk Factors” in our Annual Report on Form 10-K for fiscal 2023.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
No shares of our Class A Common Stock were repurchased during the fiscal quarter ended March 31, 2024.
Item 5. Other Information
During the three months ended March 31, 2024, none of the Company’s directors or Section 16 reporting officers adopted terminated
63
Item 6. Exhibits, Financial Statement Schedules.
The exhibits listed below are filed as part of this Quarterly Report on Form 10-Q:
| Exhibit Number | Description | |||||||
| 101.INS | Inline XBRL Instance Document. | |||||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. | |||||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | |||||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. | |||||||
| 101.LAB | Inline XBRL Taxonomy Extension Labels Linkbase Document. | |||||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | |||||||
| 104 | Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101). | |||||||
| † | Exhibit is a management contract or compensatory plan or arrangement. | |||||||
64
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| COTY INC. | |||||||||||
| Date: May 7, 2024 | By: | /s/Sue Nabi | |||||||||
| Name: Sue Nabi | |||||||||||
| Title: Chief Executive Officer | |||||||||||
| (Principal Executive Officer) | |||||||||||
| /s/Laurent Mercier | |||||||||||
| Name: Laurent Mercier | |||||||||||
| Title: Chief Financial Officer | |||||||||||
| (Principal Financial Officer) | |||||||||||
65
Exhibit 10.1
THIS SETTLEMENT AGREEMENT is made on 6 February 2024
BETWEEN:
(1) COTY MANAGEMENT B.V., a private limited liability company incorporated under the laws of the Netherlands, having its registered seat in Amsterdam, the Netherlands, and its office address at Buitenveldertselaan 3-5,1082 VA Amsterdam, the Netherlands, hereinafter: the Company; and
(2) GORDON VON BRETTEN, born on [XXX], residing at [XXX], hereinafter: the Director;
The Company and the Director together referred to as the Parties and each of them individually as the Party.
WHEREAS:
a)the Director entered into the Company’s employment with effect from 3 June 2020 on the basis of an indefinite term employment agreement (the “Employment Agreement”);
b)the Director was appointed as managing director (statutair directeur) of the Company by a written resolution of the general meeting of shareholders of the Company with effect from 1 July 2020;
c)the Director serves as Chief Transformation Officer of Coty Inc. (the Parent) and in such positions with the Parent, the Company or any other business entity, directly or indirectly, controlled by or under common control with the Parent (each, a Group Company and together the Group);
d)the Parties now wish to terminate the Employment Agreement in accordance with the terms set out in this agreement;
e)the Parties emphasize that the reason for termination is not an urgent cause (dringende reden) as referred to in article 7:678 of the Dutch Civil Code, and that the initiative to terminate the employment has been taken by the Company;
f)the Parties have discussed the terms and conditions of termination of the Director’s employment and corporate position(s) with the Company and/or any Group Company and wish to hereby record their agreement in this respect in writing; and
g)by concluding this settlement agreement, the Parties intend to reach a comprehensive settlement.
IT HAS BEEN AGREED AS FOLLOWS:
1.The employment between the Company and the Director will terminate by mutual consent with effect from 1 April 2024 whereby his last day of employment will be 31 March 2024 (the Termination Date).
2.The Director will continue to perform his regular duties until the Termination Date.
3.By signing this agreement, other than his role as a Director on the Board of Directors of Coty Inc. effective April 1, 2024 which shall not be impacted hereby, the Director stands down or resigns, as the case may be, with effect from the Termination Date from his role as managing director of the Company, and from all (other) employment or corporate positions he holds with the Company and/or the Group, such as supervisory and management board positions, and all other positions that the Director holds in his capacity as representative of the Company or the Group, like memberships of branch organisations, without cancelling the membership of the relevant members of the Company or the Group to those organisations. The Director undertakes to sign such documentation and take such actions as may be required to give effect to the foregoing.
4.Subject to the provisions of this agreement, the Company will pay the Director his regular salary and provide him with his regular benefits, until the Termination Date.
5.Any expenses not yet claimed and relating to the period up to the Termination Date will be reimbursed in accordance with the normal expense policies of the Company, provided that a request for reimbursement will have been submitted to the Company ultimately on the Termination Date.
6.Within one month after the Termination Date, and provided that the Director has complied with all his obligations from this agreement and the Employment Agreement, the Company will pay to the Director an amount of EUR 325,000 gross as a payment in lieu of notice (the PILON). The PILON is deemed to include any compensation to which the Director may be entitled in relation to the termination of his employment. This includes but is not limited to any compensation for loss of income and benefits of whatever nature relating to the employment or any other positions held by the Director with the Group, including the termination thereof, such as entitlements arising from the use of company property and contributions to private insurance and pension arrangements. The PILON will be paid to the Director in the Netherlands, less applicable taxes and social security premiums.
7.Within one month after the Termination Date, the Company will effect a normal final payment (eindafrekening) in the Netherlands, subject to the provisions of this agreement. The holidays accrued but untaken by the Director up to the Termination Date will be paid out on the basis of Base Salary as defined in the Employment Agreement, which is deemed to include 8% holiday allowance. The Director’s pension will be made premium
free (premievrij) in accordance with the law and the rules of the relevant pension plan. Any benefits, insurances and pension plans, if any, that Director participates in pursuant to the Employment Agreement, will end on the Termination Date or, if earlier, the last day of the employment.
8.Any loans or advance payments provided to the Director by the Company and/or the Group become repayable as of the Termination Date or, if earlier, the last day of the employment. The amount of the loans or advance payments will be set-off (verrekenen) against any amount owed to the Director by the Company and/or the Group. The Director must immediately repay any amount thus remaining to the Company and/or the relevant Group Company.
9.The Director’s rights under the Amended and Restated Coty Inc. Equity and Long-Term Incentive Plan (the ELTIP) will be settled in accordance with the relevant scheme rules, but notwithstanding the Director’s continuing role as a director on the Board of Directors of Coty Inc. effective April 1, 2024, and, with his explicit consent, be forfeited with the exception of 193,574 shares of restricted stock which shall vest on the Termination Date.
10.The Company will contribute an amount of at maximum EUR 5,000 gross exclusive of VAT towards legal fees incurred by the Director in respect of legal assistance in connection with the termination of his employment, which amount shall be paid directly to his legal adviser(s) upon receipt by the Company of (an) original specified invoice(s) in the name of the Director, but marked payable by the Company.
11.Ultimately on the Termination Date, the Director will return to the Company and/or any other party designated by the Company all property of the Company and/or the Group, and all other items made available to him by or on behalf of the Company and/or the Group in connection with the performance of his job, including, but not limited to: company car, smartphone, tablet, laptop, other computer equipment, any and all files, software and diskettes, credit cards, keys, documents, papers, records, notes, agenda, memoranda, plans, calendars, and other books and records of any kind and nature whatsoever containing information concerning the Company and/or the Group, their customers or operations. The Director herewith confirms that he will not retain copies of any such property or other materials. The Director confirms that he will until the date of return, use any company property in line with the rules and procedures applicable within the Company and/or the Group in that respect.
12.The Director confirms that he will not disclose, divulge, or communicate any negative or damaging information about the Company and/or the Group, the controlling shareholders and/or their ultimate beneficial owners.
13.The Director will keep strictly secret and confidential the existence and contents of this agreement, as well as any other information relating to the settlement or the termination of
the Employment Agreement, unless vis-à-vis the Director’s civil partner or legal advisors or in case this would be required for the proper implementation of this agreement or as a result of a legal obligation to disclose such information.
14.Any confidentiality and intellectual property clauses as agreed upon between the Director and the Company and/or the Group in the Employment Agreement and/or the confidentiality, non-competition and non-solicitation agreement signed by the Director (RCA) will remain in full force up to and after the Termination Date, in accordance with their terms and including the penalties agreed in case of violation. Subject to the terms and conditions as agreed upon in the RCA, the Company shall pay the Director compensation for any period that the Director is restricted from accepting employment or other remunerative association during the Restricted Period as defined in the RCA.
15.The Director confirms that he will change any social media profiles (LinkedIn, Facebook, X and any other relevant media being applicable) ultimately at the Termination Date, so that it is unambiguously clear that the Director is no longer employed by the Company. In addition, the Director shall ensure that the information provided in any of his social media profiles concerning his employment with the Company is accurate, including but not limited to the position, tasks and responsibilities and the duration of the employment.
16.Whether or not the Director is granted a benefit pursuant to the applicable social security laws after the Termination Date, and whether or not a punitive cut is applied, or such benefit is suspended, this will not change this agreement. Any loss that Director might suffer is deemed to be included in this agreement so that the Company will not be obliged to make any additional payment.
17.Subject to the provisions of this agreement, the Director hereby grants the Company and/or the Group full and final discharge as regards any rights or claims he may have towards them following from his employment and/or any other positions he holds with the Company and/or the Group, or the termination thereof.
18.The Director has been advised by the Company to seek professional legal advice before accepting the terms and conditions as laid down in this agreement, and the Director confirms that he fully understands the terms and conditions of this agreement and is fully aware of all of the implications arising therefrom.
19.If the Director becomes incapacitated for work before the Termination, this shall not change the arrangements made in this agreement. If the Director becomes ill prior to the Termination Date or, if earlier, the last day of his employment or within four weeks after the Termination Date or, if earlier, the last day of his employment, the Director shall immediately report this to the Company in writing and provide his contact details. The Director will be obliged to (i) report to the company doctor upon first request, (ii) at all times provide his full cooperation to applicable reintegration obligations, and (iii) provide
the Company with all information which it needs to submit to the Director, Insurance Agency (UWV) or other relevant authorities in this respect. If the Director does not comply with the applicable reintegration obligations, the right of continued payment of wages shall cease. If the Director is eligible for benefit under the Dutch Sickness Benefit Act (Ziektewet) or Work and Income (Capacity for Work) Act (WIA) or the Return to Work (Partially Disabled Persons) Regulations (WGA), the Director must strictly comply with the rules and regulations in respect of sickness and incapacity for work as issued by the UWV.
20.All amounts payable under this agreement are gross amounts. The Director will bear all regular wage tax and income tax, as well as any employee social security contributions due in relation to all the amounts payable and benefits granted under this agreement and indemnify and hold harmless the Company and any Group Company for all these taxes and premiums payable in respect of such amounts. For the avoidance of doubt, this indemnification shall not apply to any other taxes, interest and penalties payable by the Company and/or any Group Company in respect of the amounts payable and benefits granted under this agreement.
21.This agreement constitutes a settlement agreement (vaststellingsovereenkomst) in accordance with article 7:900 and further of the Dutch Civil Code. The Parties to this agreement irrevocably waive their right to seek rescission and/or annulment of this agreement, it being understood that this will not prevent the Company from summarily dismissing the Director prior to the Termination Date based on an urgent cause as meant in article 7:678 of the Dutch Civil Code, in which case the Director will no longer be entitled to any financial right under this agreement with the exception of his regular salary and benefits until the last day of his employment.
22.This agreement represents the entire understanding and agreement reached between the Parties in respect of the termination of the Director’s employment and corporate position(s) with the Company and/or the Group. This agreement supersedes all previous agreements, both oral and in writing, including correspondence, in relation to such subject matters. Modifications and/or amendments to this agreement shall only be valid if agreed in writing between the Parties.
23.This agreement shall be governed by and construed in accordance with the laws of the Netherlands.
24.All disputes arising out of or in connection with this agreement shall be submitted in the first instance to the competent court in Amsterdam.
In witness whereof this agreement was executed in duplicate and signed by the Parties:
For Coty Management B.V.: For acceptance:
/s/ Kristin Blazewicz /s/ Gordon von Bretten
Name: Kristin Blazewicz Name: Gordon von Bretten
Date:February 6, 2024 Date: February 6, 2024
Coty International Holding B.V.:
/s/ Raphael Fauvel
Name: Raphael Fauvel
Date:February 6, 2024
Exhibit 31.1
Certification
I, Sue Nabi, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Coty Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: May 7, 2024
| /s/Sue Nabi | ||||||||
| Sue Nabi | ||||||||
| Chief Executive Officer | ||||||||
Exhibit 31.2
Certification
I, Laurent Mercier, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Coty Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: May 7, 2024
| /s/Laurent Mercier | ||||||||
| Laurent Mercier | ||||||||
| Chief Financial Officer | ||||||||
Exhibit 32.1
Certification
Pursuant to Rule 13a-14(b) or
Rule 15d-14(b) and 18 U.S.C. Section 1350
(as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002)
Pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002), the undersigned officer of Coty Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The quarterly report on Form 10-Q for the quarter ended March 31, 2024 (the “Report”) of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (15 U.S.C. 78m or 78o(d)), and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: May 7, 2024 | /s/ Sue Nabi | |||||||
| Sue Nabi | ||||||||
| Chief Executive Officer | ||||||||
The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and for no other purpose.
Exhibit 32.2
Certification
Pursuant to Rule 13a-14(b) or
Rule 15d-14(b) and 18 U.S.C. Section 1350
(as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002)
Pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002), the undersigned officer of Coty Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The quarterly report on Form 10-Q for the quarter ended March 31, 2024 (the “Report”) of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (15 U.S.C. 78m or 78o(d)), and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: May 7, 2024 | /s/Laurent Mercier | |||||||
| Laurent Mercier | ||||||||
| Chief Financial Officer | ||||||||
The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and for no other purpose.